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ABSTRACT 
Embryonic stem cells, with the ability of self-renewal and differentiation to generate cells 
of all three germ layers, are promising sources to address developmental questions and also for 
use in clinical regenerative medicine. Generating lineage-committed intestinal stem cells from 
embryonic stem cells (ESCs) could provide a tractable experimental system for understanding 
intestinal differentiation pathways and may ultimately provide cells for regenerating damaged 
intestinal tissue. Intestinal organoids are multicellular crypt-like structures that can be derived 
from isolated intestinal stem cells or from embryonic stem cells (ESCs) following described 
differentiation procedures. In addition to their potential usefulness in tissue repair, intestinal 
organoids may also be useful as tissue surrogates to study basic aspects of intestinal cell biology 
and for the identification of novel compounds for intestinal diseases and disorders. 
In this work, we first generated a two-step differentiation procedure in which ESCs were 
first cultured with activin A to favor formation of definitive endoderm, and then treated with 
fibroblast-conditioned medium with or without Wnt3A to generate intestinal organoids. The two-
step differentiation protocol generated gut bodies with crypt-like structures that included regions 
of Lgr5-expressing proliferating cells and regions of cell differentiation. The ability of the 
definitive endoderm to differentiate into intestinal epithelium was supported by the vivo 
engraftment of these cells into mouse colonic mucosa. These findings demonstrate that definitive 
endoderm derived from ESCs can carry out intestinal cell differentiation pathways and may 
provide cells to restore damaged intestinal tissue. 
 Li Cao – University of Connecticut, 2013 
We next analyzed their cellular compositions of ESC-derived intestinal organoids under 
different conditions. We found that the resulting organoids were enriched for intestinal stem cells 
expressing intestinal stem cell markers Lgr5, Msi1, Tert and Dclk1, relative to cells stripped from 
colonic mucosa. Similar to intestinal crypt cells, the Tert and Lgr5 expressing cells resolved into 
two distinct populations. Under two different differentiation procedures, the intestinal stem cell 
population was found to be largely unaffected whereas the expression of secretory vs. absorptive 
cell genes could be altered. Finally, intestinal organoids derived from cancer-prone ApcMin/+ mice 
showed reduced Atoh1 expression, as reported for native intestinal tissue, indicating that aberrant 
differentiation signaling is reproduced in the organoid system. Our data support the use of ESC-
derived intestinal organoids as tissue surrogates for the study of early events in intestinal stem 
cell differentiation. We propose that these organoids may be particularly useful for modeling 
colonic mucosa at risk for cancer development.           
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CHAPTER 1 
GENERAL INTRODUCTION 
 
Embryonic stem cells (ESCs) are undifferentiated cells derived from the inner cell mass 
of the  blastocyst, which is the spherical structure formed in the early stage of embryo 
development 1,2. These pluripotent ESCs are characterized by their ability to self-renew and to 
generate differentiated cells of all three germ layers including the endoderm, mesoderm and 
ectoderm lineages 3. Due to the capabilities of self-renewal, proliferation and differentiation, the 
ESCs have been studied to explore fundamental questions in developmental biology and used in 
clinical regenerative medical research 4. Adult stem cells, also known as somatic stem cells, are 
found in fetal and post-natal tissues or organs. The adult stem cells are infrequently cycling cells 
that maintain the capacity to self-renew and differentiate into various cell types of the tissue or 
organ from which they are derived under the regulation of appropriate signals 5. The stem cells 
persist in specific microenvironments called niches that provide a protected environment and 
produce essential factors to maintain the mitotically quiescent status and the ability to undergo 
asymmetric division to generate active cycling daughter cells, or so-called progenitors. Once they 
leave the niche, they proceed to differentiation 6. The induced pluripotent cells (iPSCs) are derived 
from adult cells that were originally produced to avoid immunogenic responses, but even these cells 
are immunogenic 
7
.  
Although it is believed that stem cells can be used as  potential sources of regenerative 
applications, a number of stem cell based therapies are still in experimental stages due to technical 
limits or costs. Recently, researchers developed cell culture protocols to generate multi-cellular 
structures termed organoids. Intestinal organoids (IOs) are crypt-villus like structures generated from 
human or mouse ESCs, iPSCs, and adult stem cells 
8–10. The ability of ESC-derived IOs to grow 
quickly and in relatively large quantities make them a potential model for study of developmental 
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signaling, drug screening, understanding disease progression, and assessing potential treatments. 
The work presented herein highlights the protocol we developed to generate IOs from ESCs, 
and the analysis of genes expression in cells that make up the IOs. We also discuss the potential of 
using IOs as tissue surrogates for intestinal epithelium related studies.    
Intestinal Stem Cell 
The small intestine and large intestine (colon) are two anatomically and functionally 
distinct organs of the gastrointestinal tract. The major functions of the small intestine are to digest 
food and absorb nutrients and minerals. Nutrients including proteins, lipids and carbohydrates are 
degraded into small peptides/amino acids, fatty acids/glycerol, and monosaccharides  by digestive 
enzymes in small intestine. These nutrients are then absorbed through the mucosa of the small 
intestine. The colon is the last part of the digestive system, which continues from the bottom end 
of the small intestine.  The colon absorbs water, mineral ions, and vitamins from the indigestible 
residue of food.  
The intestinal epithelium lining the gastrointestinal tract is a single layer cells consisting 
of four subtypes of cells with specialized physiological functions to either serve as barriers 
between the intestinal lumen and underlying sterile mucosa, or play a critical role in nutrient and 
water absorption 11,12. The intestinal epithelium is a rapid dynamic tissue with a turnover rate for 
the entire epithelial lining every 3-5 days in adult mammals 12. Therefore, an efficient mechanism 
is required to maintain homeostasis of intestinal epithelium. The intestinal stem cells (ISCs), with 
the properties of self-maintenance and potential capacity to produce all cell lineages, have the 
ability to supply new cells and repopulate the mucosa to support normal epithelial homeostasis 
throughout life 13.  
The first work that identified the existence of ISCs was carried out by a microcolony 
experiment in 1970’s. In this study, single cells within the crypt survived after irradiation to 
produce all cell types, and regenerated the whole crypt 14. The exact number and location of ISCs 
are not established; however, there is a general agreement that approximately 4-6 independent 
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stem cells are located at base of the crypt. Researchers then generated two models of ISC identity 
using genetic lineage tracing and transplantation experiments: (1) cell position 4 from the bottom 
of the crypt, just above the Paneth cells, or (2) the small undifferentiated cycling cells called crypt 
base columnar (CBC) cells interspersed between the Paneth cells in the base of crypt 13,15. In +4 
model of ISCs identity, ISCs reside directly above the noncylcing Paneth cells (+4 position on 
average) and are radiation-sensitive, label-retaining and actively proliferating cells with a cell 
cycle time of 24 hrs 13,16.  In the stem cell zone model, CBCs are characterized as radiation-
sensitive, non-label retaining and actively proliferating cells with a cycle time of 24 hrs. The adult 
stem cell niche of the intestine is supported by proliferating epithelial cells and subepithelial 
myofibroblasts, which produce proteins, growth factors and cytokines to maintain the stem cell 
self-renewal  and promote proliferation.  
The luminal protrusions called villi and bottle-shaped invaginations called crypts are 
structural and functional fundamentals of the intestinal epithelium lining in the gastrointestinal 
tract. To continuously produce new intestinal epithelial cells, ISCs residing in the base of the 
crypts generate transit-amplifying cells (TA cells) under the induction of specific signaling 
molecules and migrate along the crypt-villus axis to differentiate to predominant absorption 
enterocytes, mucus-secreting Goblet cells, and peptide hormone secreting enteroendocrine cells. 
TA cells also migrate toward the bottom of the crypt and differentiate to a fourth cell type; the 
anti-microbial compounds secreting Paneth cells 17. Defined cell markers play important roles on 
identification and isolation of ISCs, and understanding the relationships between these markers is 
a useful tool to elucidate the mechanisms of stem cell function and regulation. Some researchers 
have suggested that Musahi-1(Msi1)  18,19, Dclk120, Telomerase Reverse Transcriptase (Tert) 21, 
and Lgr5 22,23 could be potential ISC markers based on the knowledge of their localization, 
abilities of crypt regeneration or organoid formation from single isolated cells.  
Wnt signaling pathway 
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The Wnt genes are an evolutionarily conserved family of extracellular signaling 
molecules which were initially found and named as Wng in Drosophila and Int1 in mouse. The 
Wnt signaling pathway has been identified as an important pathway that controls diverse 
processes in embryogenesis, adult tissue homeostasis, and disease development
24
. During the 
canonical pathway, a lack of the Wnt protein leads to β-catenin phosphorylation, ubiquitination 
and degradation by glycogen synthase kinase 3 (GSK-3), adenomatous polyposis coli (APC), and 
Axin complex, resulting in the inhibition of downstream gene expression. In the presence of Wnt 
ligands, Wnt signaling proteins bind to the Frizzled/low-density lipoprotein receptor-related 
protein (LRP) family receptors on the surface of target cells, scaffolding proteins Axin are 
removed from the GSK-3/APC/Axin complex in cytoplasm, thereby inhibiting the proteasome-
mediated degradation of β-catenin in cytoplasm. The accumulated β-catenin in the cytosol then 
enters the nucleus and interacts with the lymphoid enhancer-binding factor 1 (LEF)/T cell 
specific transcription factors (TCF), and subsequently induces the transcription of target genes
25
. 
The non-canonical Wnt signaling including the planarcell-polarity (PCP) pathway and Wnt/Ca 
2+
 
pathway are important in cell movements during gastrulation and cell adhesion regulation 
26
.  
The Wnt signaling components are expressed in a wide variety of tissues and are 
implicated to play important roles in stem cell regulation, including cell proliferation, 
specification, differentiation, and migration 
27,28
. Recent research demonstrates that the Wnt 
proteins (Wnt 2B, Wnt 3A, Wnt 5A, and Wnt 10B) and the Wnt receptors (Frizzled 6 and LRP-6) 
are expressed in bone marrow cells enriched for hematopoietic stem cells (HSCs) and their niches, 
indicating that HSCs can receive Wnt signaling 
29
. Further evidence also suggests that Wnt 
signaling promotes human and murine HSCs self-renewal, proliferation of undifferentiated 
progenitors; increase the ability of reconstitution of hematopoietic system of irradiated mice by 
HSCs and inhibit the differentiation in vitro. Conversely, deregulation of Wnt signaling pathway 
by overexpression of Axin leads to inhibition of HSCs growth and loss the ability of 
reconstitution of hematopoietic system of irradiated mice
29
. The Wnt signaling pathway also 
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plays crucial roles in development of the neural tube, proliferation of neural stem cells, 
maintenance of the neural procursors, and cell fate determination in the nervous system 
30
. 
Researchers found that the function of Wnts vary with different tissue types and developmental 
stages both in vitro and in vivo 
31
.  
  During the early stage of gastrulation, β-catenin is required to promote definitive 
endoderm formation 
32
. Further evidence also shows that Wnt signaling is essential for gut tube 
formation 
33
.  In the adult intestine, the Wnt signaling gradient decreases from the stem cell 
compartment region located in bottom of the crypt to upper proliferative areas, and tailing off in 
the differentiative areas 
34. Loss of Tcf4, β-catenin, or overexpression of the Wnt inhibitor Dkk-1 
leads to loss of transit-amplifying cells in intestine 
35–37
, whereas mutations on APC or 
overexpression of β-catenin result in hyperproliferation of the epithelium 38–41.  Loss of 
transcription factor TCF4 in the crypt leads to depletion of stem cells 
35
.   
Normal level of endogenous Wnt signaling regulates intestinal homoeostasis, whereas 
aberrant Wnt signaling causes intestinal tumorigenesis. Mutations in the Wnt pathway; such as 
the loss of APC or gain of activated β-catenin, increase the level of stable β-catenin leading to 
constitutive activation of the nuclear β-catenin/TCF transcription factor complex resulting in the 
formation of colon polyps that can develop into carcinomas 
42
. Given that the Wnt pathway is 
important to several diseases, especially colorectal cancer, synthetic Wnt inhibititory compounds, 
monoclonal antibodies and natural products have been tested for Wnt pathway inhibition. 
However, only few of them (PRI724 compound, OTSA011 against Frizzled homolog, and a 
plant-derived natural phenol) are included for the colorectal cancer prevention 
43
.  
Notch signaling pathway  
 Notch signaling pathway is an evolutionarily conserved signaling pathway that regulates 
cell-fate determination during development and adult tissue homeostasis 
44,45
. Notch proteins, the 
single-pass transmembrane receptors with multiple epidermal growth factor-like repeats followed 
by conserved cysteine-rich Notch/Lin12 repeats and cdc10/ankyrin repeats, can interact with 
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ligands (Delta/Jagged) to trigger Notch signaling. After binding with ligands, the Notch 
intracellular domain (NICD) is released by sequential proteolytic processing catalyzed by 
ADAM-family metalloproteases and γ-secretase and translocates into the nucleus. NICD then 
associates with a DNA binding protein CSL and its coactivator; Mastermind, to assemble a 
transcription complex that activates the transcription of downstream target genes
46–48
. 
 In the intestinal epithelium, Notch pathway components including Notch ligands, 
receptors, and the Notch target genes; Hes1 and Hes5, are restrictedly expressed in proliferating 
crypts in different stages of differentiation and development 
49–51
. Studies have shown that 
activation of Notch signaling contributes to intestinal epithelial homeostasis by promoting 
proliferation of ISCs/progenitor cells 
52
 and promoting the absorptive cell fate determination 
52–54
.  
Notch inhibition led to the loss of crypt base columnar cell, thus reduced proliferation and 
disturbed intestinal organoids formation. Notch inhibition also induced differentiation of 
epithelial progenitors into all secretory cell types, with increasing number of enteroendocrine, 
Paneth cells, tuft cells, as well as goblet cells 
55
. 
 Overexpression of Notch signaling has been observed during the carcinogenesis of 
various cancers including colon cancer 
56
. Studies found that the upregulation of Notch signaling 
target genes leads altered goblet cell differentiation and mucin formation in patients with colonic 
precancerous conditions as inflammatory bowel diseases 
57
. Increased expression of Notch 
recepters, ligands, and downstream targets including Hes1, Deltex and NICD are also found in 
colorectal cancer compared with normal colonic mucosa 
58
. Two Notch-targeting approaches, γ-
secretase inhibitors and small interfering RNA (siRNA)-mediated knockdown of Notch receptors, 
notch ligands, and Notch downstream targets, have been studied for the colorectal cancer therapy 
58. γ-secretase inhibitors suppressed growth of colon cancer cell lines HT29 and HCT116, and 
sensitized colon cancer cell lines to chemotherapeutic agent-induced cell apoptosis and growth 
inhibition 
59,60
.  Studies also found that siRNA-mediated knockdown of Notch1 and Jaggled1 
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were able to inhibit cell proliferation and migration in colon-derived HT29 and HCT116 cell lines 
59
.  
ISC markers 
Musashi-1  
Musashi, an evolutionarily conserved neural RNA-binding protein, was first reported to 
play essential roles in the development of adult external sensory organs (sensilla) in Drosophila 
61. It regulates target genes at the post-transcriptional level and controls asymmetric cell division 
through the Notch signal pathway62. Mouse Musashi-1 (Msi1) has been proposed as an adult stem 
cell marker in several mammalian organs including the nervous system63, hair follicles64, and 
mammary glands65. In the mammalian nervous system, Msi1 represses synthesis of an 
intracellular Notch antagonist m-Numb, thus activating the Notch signaling pathway to maintain 
the undifferentiated state of mammalian neural stem cells66. In mouse intestinal epithelium, Msi1 
positive cells are observed selectively expressed in few epithelial cells at the base of the crypt, 
including cell position 4, the putative position of stem cells 18. Recent study revealed that Msi1-
positive cells derived from mouse ESCs, when hypodermically engrafted into the back of 
NOD/SCID mice, can differentiate into neural and intestinal epithelial cells 19. 
Dclk1 
Doublecortin and CaM kinase-like-1 (Dclk1), a microtubule-associated kinase expressed 
in post-mitotic neurons, has been recently identified as a putative ISC marker 67. Dclk1 
expression was observed in a limited number of gut epithelial progenitors within the stem cell 
niche of the stomach and small intestine crypts 68. Investigators then demonstrated that Dclk1-
expressing cells undergo apoptosis after 24 hours following 6 Gy of whole-body ionizing 
radiation (IR), a p53-independent wave of apoptosis that primarily affects stem cells 67. Dclk1 
expressing cells were restored in the regenerative crypts 7 days after lethal dose of IR treatment, 
and were not proliferating and therefore quiescent 67. Isolated single Dclk1 positive cells can form 
spheroids in suspension culture, which when injected into nude mice induced nodular growths on 
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the flank with glandular epithelial and intestinal epithelial lineage commitment 20. 
Immunofluorescence microscopy and double immunostaining revealed colocalization of Dclk1 
and Msi1 in the stem cell zone of crypt in adult mouse intestine indicating that Dclk1 and Msi1 
are co-expressed in the subset of Msi1 expressing cells 67. 
Lgr5 
Lgr5, an orphan G-protein coupled receptor with a large leucine-rich-repeat extracellular 
domain and seven transmembrane domain, was initially identified as a Wnt target gene in colon 
cancer, and then was found expressed in other tissues like ovary and liver cancer 69–71. The 
expression of Lgr5 in the embryo is dynamic with a complex pattern. However, in adults, Lgr5 
expression is detected in scattered cells in a variety of tissues including intestine, hair follicle, 
eye, brain, mammary gland, reproductive organs, and stomach 72. Both heterozygous Lgr5-LacZ 
knock-in mice and Lgr5-EGFP knock-in mice identified the Lgr5 restrictively localized at the 
proliferative crypt bottom of intestine, especially in the columnar cells between the Paneth cells 
22. The genetic lineage tracing experiment also revealed that the Lgr5-positive cells have the 
ability to self-renew, multiply, and generate the entire epithelium containing goblet cells, 
enterocytes, enteroendocrine cells, and Paneth cells 72. Recently, scientists generated crypt-villus 
organoids from single Lgr5 stem cells under long-term culture conditions. Four types of mature 
epithelium cells derived from single stem cells were confirmed with normal morphology and 
function 23. Although the these findings suggest that Lgr5 serves as a stem cell marker of the 
intestinal epithelium, the Lgr5-expressing cells are not quiescent with a cell cycling rate of once 
per day 73.  
Tert 
Tert, known as telomerase reverse transcriptase, is a part of the telomerase complex 
which controls telomere length and plays an important role in stem cell, aging, and cancer. β–
catenin regulates activity of Tert promoter in ESCs and adult stem cells, thus regulating the 
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expression of Tert in cells 74. Mouse telomerase reverse transcriptase (mTert) expressing cells 
localize to single cells in the intestinal crypt, but distinct from ISCs expressing Lgr5. Unlike 
rapidly cycling Lgr5-expressing cells, the mTert-expressing cells are slow cycling and mark 
label-retaining cells (LRCs) within the intestine. mTert-exprssing cells are resistant to the 
radiation, give rise to Lgr5-expressing cells 21.  
Impact of this study 
The constant turning over of the intestinal epithelium and lineage tracing experiments 
have provided evidence that there are stem cells populations marked with several ISC markers, 
including Lgr5, Tert, Dclk1, in the base of intestine crypts. Lgr5 expressing cells are actively 
cycling cells, which have been identified to be CBC cells located between the Paneth cells at 
positions +1 – 3 from the crypt base. These  rapid cycling ISCs are relatively radioresistant 75, and 
can generate all cell lineages of the intestinal epithelium over the lifetime of the animal22. Unlike 
the rapid cycling ISCs, slow cycling ISCs marked by Tert and other markers are positioned at 
position +4 relative to the crypt base and were initially identified as DNA label-retaining cells21. 
Although no present data shows co-localization of Lgr5 and Tert in the cells, inter-conversion 
between Lgr5- marked cells and Tert marked +4 cells has been detected by lineage tracing 
experiments 21.  The Dclk1 positive cells positioned in crypt base are quiescent, but isolated 
single Dclk1 expressing cells can proliferate and generate glandular structures in the flanks of 
athymic mice 67. However, unlike Lgr5 and Tert, Dckl1 expressions have been also detected in 
mature Tuft cells 76. Dckl1 may therefore mark a differentiated cell type that can serve as a stem 
cell pool under some circumstances. Co-expression of  Dclk1 and  Lgr5 has been detected in 
some cells by in situ hybridization experiments 77. Radiation-induced apoptosis studies have 
provided evidences that there are multiple stem cell populations in the intestine. One possibility is 
that they can all serve as stem cells under different conditions, for example, Lgr5-expressing 
CBCs are considered as the primary source of cell renewal in the intestine epithelium, while the 
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+4 ISCs serve a stable source of slowly dividing cells 78. The usefulness of these markers for 
guiding the differentiation and lineage commitment of stem cells in culture is not yet clear, and 
the precise relationship between cells expressing these ISC markers is not clear either. To evaluate 
the potential of differentiating ESCs to intestinal lineages and to understand signaling pathways 
involved in intestine development, we developed a procedure to generate intestinal lineage from 
ESCs directly and tested the potential reparative capacity of definitive endoderm cells in the first 
part of this study.   
Recently, researchers have developed technology to generate IOs from mouse or human 
isolated ISCs, iPSCs or ESCs 8–10. These IOs are organized crypt-villus like structures and 
comprised of ISCs and intestinal lineages of intestine. In addition, these IOs can be maintained in 
defined medium for long term culturing 23. Thus, the IOsare particularly useful as tissue 
surrogates for determining the relationship between the ISCs expressing different markers and 
studying events in the differentiation process. Unlike laborious, costly, and time-consuming 
mouse models and transformed cell lines, generating and maintaining organoids are easily 
manipulated, economic, and time-saving. ESC-derived IOs could be also applied for screening of 
biological agents and small molecules to investigate signaling mechanisms that control the 
growth and differentiation of intestine and uncover novel pharmacological targets. In addition to 
the wild type ESC-derived IOs, organoids can be generated from ESCs of other genetic 
backgrounds, which is specific facilitated to disease studies. However, the composition of ESC-
derived organoids under different culture conditions are not clear, especially their relation to 
intestinal mucosa. In the second part of this study, we performed a detailed comparison of 
composition of mouse ESC-derived intestinal organoids and intact mouse intestinal mucosa, and 
characterized IOs under different growth conditions using single-cell transcript profiling.  
In general, differentiation of ESCs to intestinal lineages in this study provides a technology to 
generate and maintain intestinal organoids in culture system. The IOs can be employed for the 
research on ISCs and early stages of differentiation. They may be useful tools for high throughput 
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screening for agents and small molecules in disease research in the future.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
ESCs maintenance 
C57BL6/N, GFP transgenic mouse ESCs (GlobalStem, Rockville, MD) and ApcMin/+ 
mouse ESCs were maintained on primary mouse embryo fibroblasts (MEFs) in DMEM media 
supplemented with 15% fetal bovine serum (FBS), 1% nucleosides, 1% Pen-Strep, 1% non-
essential amino acids, 1% L-glutamine, 1% β-mercaptoethanol and 1000 units/mL ESGRO® 
(LIF) at 37 °C, 5% CO2  (table 1). All the reagents were Chemicon EmbryoMax ES Cell products 
and purchased from Millipore Corporation (Billerica, MA). mESCs were checked and changed 
medium, removed differentiated colonies daily mESCs were washed with PBS and passaged 
using trypsin-EDTA as needed. H9 human ESC (WA09) were maintained on MEFs in DMEM-
F12 media supplemented with 20% knockout serum replacer, 1 mM (0.5%) L-glutamine, 0.1 mM 
(1%) non-essential amino acids, 0.55 mM β-mercaptoethanol and 4 ng/mL bFGF (all from 
Invitrogen) (table 1). Human ESCs were mechanically passaged using 1.0 mg/mL (1.0%) 
collagenase (Gibco) and washed 3× with PBS prior to induction of differentiation. 
Preparation of conditioned media 
Mouse fibroblast L cells and L cells expressing Wnt3A purchased from ATCC (Manassas, 
Virginia) (table 1)  and maintained in complete growth medium containing DMEM medium 
supplemented with 10% FBS and  DMEM medium supplemented with 10% FBS with 0.4 mg/mL 
G-418 respectively. Control conditioned medium and Wnt3A conditioned medium were prepared 
according to the ATCC protocol. Briefly, 1:10 diluted cells are cultured in 10ml DMEM/FBS in 
T75 flasks for 4 days. Carefully transfer medium from day 4 cultures and sterile filter, save at 4°C 
as first batch of medium. Add fresh pre-warmed DMEM/FBS in the flasks and culture for another 
3 days, collect and sterile filter the second batch of medium at day7 as above. Mix medium 
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collected on day 4 and day 7 at 1:1 ratio, filter through 0.2 µm filter system, aliquot and save at -
20 °C for future use. 
Activin A induced differentiation and conditioned media- induced differentiation  
Media and reagents not otherwise specified were purchased from Invitrogen (Carlsbad, 
CA). Undifferentiated ESCs were separated from MEFs by panning in serum-free differentiation 
media (SFD) containing 75% IMEM, 25% Ham’s F12 media supplemented with 0.5X N2 
supplement, 0.5X B27 supplement, 1% Pen-Strep, 2 mM L-glutamine, 0.05% BSA (Sigma-
Aldrich, St. Louis, MO), 0.5 mM ascorbic acid (Sigma-Aldrich), and 0.45 mM 1-thioglycerol 
(Sigma-Aldrich) overnight. ESCs were then collected and re-suspended in SFD for two days to 
form embryoid bodies (EBs). Activin A (R&D systems, Minneapolis, MN) was supplemented in 
SFD to a final concentration of 50 ng/mL on day 2 and day 4 when changing the medium. 
Definitive endoderm EBs were either harvested on day 6 or subjected to further treatment to 
generate intestinal organoids. 
Definitive endoderm EBs were transferred into 50 mL tube and settled down via gravity, 
wash three times with PBS before further treatment in different conditions:  1) 30% Wnt3A 
conditioned media (Wnt CM) with medium changed every four days; 2) medium containing 500 
ng/ml Wnt 3A and 500 ng/ml FGF4 for four days followed by intestinal organoid media 
supplemented with 500 ng/ml R-Spondin1, 100 ng/ml Noggin and 50 ng/ml EGF (IOM). The γ-
secretase inhibitor, N-[N-3,5-Difluorophenacetyl]-L-alanyl-S-phenylglycine Methyl Ester 
(DAPM; Calbiochem, San Diego, CA) was used from day 12 to day 14 at a final concentration of 
10 μM as needed. 
Differentiation of H9 was initiated under serum-free induction conditions for 2 days in 
RPMI1640 media (Gibco) containing GlutaMAX (Invitrogen), 100 ng/mL activin A (R&D 
Systems), and 25 ng/mL Wnt3A (R&D Systems, Minneapolis, MN) to induce expression of 
mesendoderm markers as Zorn and Wells79. Removal of Wnt3a and addition of 0.5% FBS and the 
PI3kinase inhibitor LY294002 (Biomol, Plymouth Meeting, PA) for 2 additional days induced 
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definitive endoderm gene expression and repression of extra-embryonic endoderm markers as 
McLean et al.80. 
Real-time quantitative PCR 
Total RNAs were extracted using TRIzol® Reagent (Invitrogen, Carlsbad, CA) following 
the manufacturer's instruction. cDNAs were synthesized with high capacity cDNA reverse 
transcription kit (Applied Biosystems, Foster city, CA) and stored at −20 °C until using. TaqMan 
gene expression assays were purchased from Applied Biosystems (Table 2). A 10 μl reaction 
mixture containing Taqman 2X PCR master mixture, 80 ng cDNA, and 2 μl Taqman gene 
expression assays was prepared for real-time quantitative PCR. Reactions were performed for 40 
cycles (50 °C 20 s, 95 °C 15 s, and 60 °C 1 min) using an Applied Biosystems 7300 Fast Real-
time PCR system. 
Animals 
Male C57BL/6 mice were purchased form Taconic (Germantown, NY, USA). Mice were 
maintained in a temperature-controlled, light-cycled room, and allowed free access to drinking 
water and standard diet (LM-485, Harlan Teklad). Animals were weighed every day and mice 
were checked daily for signs of weight loss or lethargy indicating intestinal obstruction or anemia 
associated with tumors. Animal experiments were conducted with approval from the Center for 
Laboratory Animal Care committee, University of Connecticut Health Center. 
Induction of experimental colitis 
Dextran sulfate sodium (DSS, MW 36 000–50 000) was purchased from MP Biomedicals 
(Solon, OH). Mice were administrated 2% (w/v) DSS in drinking water for 1 week, starting 7 
weeks age. 
Intracectal engraftment of definitive endoderm cells 
Mice were fasted for 18 h after colitis induction, and then anesthetized with 
intraperitoneal injection of Avertin (Sigma-Aldrich). Definitive endoderm bodies (day 6) were 
dissociated to single cells by Accutase (Millipore, Billerica, MA) after washing with DPBS twice 
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and resuspended in DPBS to a final density of 5×107 cells/mL. Definitive endoderm single cells 
(2×106 cells/40 μl/mouse) were injected intrarectally with a micropipette inserted through the 
anus. Mice were monitored daily for weight loss, bleeding, and rectal prolapse during the entire 
experimental period.  
Frozen section 
Mice were sacrificed by CO2 asphyxiation at 12 days after the cell injection. The entire 
colon were harvested and flushed with ice-cold PBS and excised longitudinally. Specimens were 
then fixed flat in freshly prepared 4% paraformaldehyde (PFA) at 4 °C for 1 h and stored in PBS 
overnight at 4 °C, followed by cryoprotection in 30% sucrose at 4 °C until frozen sectioning. 
Colon specimens were embedded with OCT and frozen in pre-cooled isopentane in liquid N2. 
Ten-micrometer sections were cut and transferred on plus charged slides to check GFP-labeled 
definitive endoderm cells. Slides with colon frozen sections were washed in PBS for 10 min, 
followed by MgCl2 (10 mM in PBS) for 15 min, and then washed again in PBS for 10 min. The 
slides were mounted with glycerol in PBS (50%). GFP were detected and imaged with an 
Olympus epiflourescent microscope. 
Immunofluorescence procedure 
Immunofluorescence was performed for ID2, α-smooth muscle actin (αSMA), β-catenin, 
LGR5, TFF3, and PCNA staining on paraffin embedded tissue sections of gut bodies and on the 
frozen tissue section of mice colon. All antibodies were obtained from Santa Cruz 
Biotechnologies (Santa Cruz, CA), except aSMA and LGR5, which were obtained from Abcam 
(Cambridge, MA). Gut bodies formed were fixed in 70% ethanol, embedded in HistoGel 
compound and later processed for paraffin sections. The tissue sections were deparaffinized and 
placed in Citrate buffer (10 mM pH 6.0, 0.05% Tween-20), preheated to 90–100 °C for antigen 
retrieval for 20 min. Normal goat serum was used to block non-specific binding for 30 min. The 
sections were incubated overnight at 4 °C with primary antibodies ID2 (1:100 dilution), αSMA 
(1:200 dilution), β-Catenin (1:150 dilution), LGR5 (1:200 dilution), TFF3 (1:100), Atoh1 (1:100 
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dilution), and PCNA (1:100 dilution). ID2, TFF3, and αSMA were coupled with Cy3 conjugated 
Goat Anti-Rabbit immunoglobulin, PCNA with Cy3/FITC conjugated Goat Anti-mouse 
immunoglobulin and β-catenin with Cy3 conjugated Donkey Anti-goat at 1:500 dilution in 0.01 
M PBS containing 10% sodium azide for 30 min. All the secondary antibodies not otherwise 
specified were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove PA). 
The frozen sections of colon were fixed in 4% PFA for 15 min followed by incubation in 70% 
ethanol for 1 h. After washing with 0.01 M PBS, the slides were placed in citrate buffer for 
antigen retrieval as described above. After blocking with normal goat serum, the slides were 
incubated overnight at 4 °C with PCNA. It was coupled with Cy3 conjugated Goat Anti-mouse 
immunoglobulin at 1:250 dilution in 5% goat serum. In both the procedures, nuclei were stained 
with DAPI (Invitrogen Carlsbad, CA) at a 1:100 dilution for 10 min and the images were 
captured using an Olympus epifluorescent microscope.  
Alcian blue staining was performed to visualize goblet cells in colon tissue. Slides were 
fixed in 4% PFA and then in 70% ethanol as described above, and then followed the standard 
procedure for Alcian blue staining. 
Single cell preparation and transcript analysis 
All the TaqMan ® assays were purchased from Applied Biosystems (Table 1). 
Definitive endoderm and intestinal organoids were incubated with Accumax with gentle 
trituration every 5 min until dispersed into single cells. Single cells were gently pelleted, washed 
with cold PBS, and then diluted in chilled serum free medium with propidium iodide (50 µg/mL 
stock) to stain dead cells. Keep cells in this solution at 4°C protected from light until sorting by 
the flow cytometer. Single cells were collected via fluorescent activated cell sorting (FACS) to 
96-well plates containing 5 µl lysis solution (0.5 µl 5% NP-40, 0.5 µl RNAsin plus, and 2 µl 0.2 
X pooled TaqMan ® assay in PBS). Cells lysates were obtained by incubating the plate at 70°C 
for 10 minutes, followed by cooling at 4°C. Five microliters reverse transcription mix containing 
5 nmol dNTPs, 100U MMLV reverse transcriptase, and 0.5 μL RNAsin plus was added to the 
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lysate in each well for the reverse transcription reaction using the program (37°C/2 min, 42°C/1 
min, 50°C/1 sec) for 40 cycles, followed by 85°C for 5min and a 4°C hold. Four microliters of 
each cDNA prep were transferred to new 96-well plate, mixed with PreAMP mixture consisting 
of 10 µl PCR Master Mix (Takara), 5 µl 0.2X Taqman Pooled Assay, and 1 µl MilliQwater. Pre-
amplification was performed using an initial temperature cycle of 95°C/3 min, 55°C/2 min, 
72°C/2 min, followed be a temperature cycle of 95°C/15 sec, 60°C/2 min, 72°C/2 min, for 16 
cycles, followed by a 4°C hold. Two microliters of a 20-fold dilution of pre-amplified cDNA, 2 µl 
of 5X TaqMan® gene expression assay, 5.0 μL 2X TaqMan® Universal PCR Master Mix, and 1 
μL ddH2O were mixed for a standard real-time Quantitative PCR using program (50°C/20 sec, 
95°C/10 sec), followed by 40 cycles of (95°C/15 sec, 60°C/10 sec) using an Applied Biosystems 
7900 Fast Real-time PCR system.  
Single cell data analysis 
Single cell qPCR data were processed as previously reported. Briefly, single-cell cycle 
threshold values (CT) from qPCR were used to normalize and cluster our data based on gene 
expression profiles. Normalization was achieved via conversion to dCT in reference to internal 
house-keeping gene values for each cell. Undetermined CT were set to be 40. All dCT values 
were reversed to obtain positive values (dCT*) directly proportionate to gene expression levels 
using the equation dCT* = 40 − dCT. Gene expression profiles were subjected to hierarchical 
clustering based on dCT* using JMP software.  
Statistic 
Bulk RNA data was analyzed using a Student’s t test for comparing two treatment groups, 
or by using an analysis of variance test (ANOVA) when comparing more than two groups. A 
Tukey’s post-hoc test was employed to determine the significance of differences between multiple 
groups, with p < 0.05 considered significant. The Fisher’s exact test was employed to analyze 2 X 
2 contingency tables to determine gene expression frequencies in different cultures. A chi-square 
analysis was performed to compare observed and expected frequencies of mRNA co-expression. 
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A probability of less than 0.05 was considered significant for these two tests.  
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Table 1. Cell lines used in this study. 
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Table 2. Markers used in this study. 
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Table 2. Markers used in this study. (Cont.) 
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CHAPTER 3 
INTESTINAL LINEAGE COMMITMENT OF EMBRYONIC STEM CELLS 
 
INTRODUCTION 
The intestinal epithelium is a highly dynamic tissue constituted of a number of 
specialized epithelial cells characterized by high rates of cell turnover 81. In addition, the 
intestinal mucosa is highly active immunologically, with epithelial cells playing a critical barrier 
function and facilitating the movement of antigens, antibodies, and anti-microbial proteins into 
and out of the intestinal lumen 82. There are many instances in which damage to the intestinal 
epithelium leads to a breakdown in its digestive, absorptive, and barrier functions. These include 
conditions such as ulcerative colitis, Crohn’s disease, and celiac disease, as well as damage 
induced by radiation and chemotherapies. Developing new approaches to save or restore 
intestinal tissue could therefore find a broad range of applications. 
During embryonic development the early gut tube is comprised of an endodermal cells 
surrounded by visceral mesoderm 79. The endoderm differentiates into the epithelial lining of the 
gut, while mesodermal cells ultimately develop into smooth muscle and other cell types of the 
intestinal wall. Signaling between the mesoderm and endoderm in the developing gut through 
Hedghog, Wnt, FGF, and other pathways helps establish anterior/posterior patterning and the 
radial differentiation characteristics of the gut 22,82–85. Within the adult intestine, epithelial cells are 
maintained through the presence of stem cells located within epithelial crypts 34,82,85. The survival, 
proliferation and multipotency of adult ISCs are maintained in a niche region where trophic 
factors are provided by adjacent mesenchymal cells, notably subepithelial myofibroblasts72,86. The 
ISC niche supports active production of Wnt ligands, which play a central role is maintaining 
intestinal epithelium. A better understanding of how the intestinal epithelium is generated and 
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maintained could provide important insight into how this tissue might be effectively repaired and 
restored following damage induced by chronic inflammatory conditions or cancer therapy. 
Cell turnover and lineage tracing analyses have identified stem cell populations within 
the intestinal crypts. These cells can be identified by their expression of a number of markers, 
including Lgr5. Lgr5 was first identified as potential ISC marker by virtue of its regulation by the 
Wnt/APC/ β-catenin pathway 87. It was subsequently shown to be expressed in a limited number 
of columnar cells present at the crypt base, and lineage tracing supports the view that Lgr5 
activation preceded cellular differentiation to all epithelial cell lineages 22. Moreover, isolated 
Lgr5-positive cells from the intestine can give rise to crypt-like structures in culture 23. Other 
markers that have been put forward as ISC markers include Msi1, Ephb2, and Dclk120,67,84,88–90. 
All of these proteins are expressed in cells near the base of the crypt. Interestingly, while Dclk1-
positive cells have been shown to generate glandular epithelial structures in athymic mice, they 
are quiescent within the crypts whereas Lgr5 cells are proliferative. The usefulness of these 
markers for guiding the differentiation and lineage commitment of stem cells in culture is not 
entirely clear. 
An important goal for generative biology is to understanding signaling pathways 
involved in tissue development and maintenance, and then exploit this knowledge to generate 
cells for tissue and organ repair. Since gut epithelial cells are derived from embryonic endoderm, 
we were interested in determining whether directing ESC development to an endodermal lineage 
could provide a source of cells for generating intestinal tissue. Here we provide evidence that 
induction of endoderm differentiation results in activation of the ISC marker Lgr5, but not Dclk1, 
Msi1, or Ephb2. Interestingly, exposure of these cells to fibroblast conditioned medium with 
Wnt3A promotes the expression of the other stem cell markers, and leads to the expression of a 
range of genes associated with early intestinal development. In addition, the endoderm cells we 
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generate are capable of associating with mouse intestinal mucosa and forming crypt-like 
structures. These characteristics are consistent with intestinal lineage commitment and a potential 
reparative capacity of these cells. We propose that endoderm-committed cells are primed to 
generate mucosal tissue and are therefore well-suited to study this differentiation pathway. These 
cells may ultimately be useful for repairing damaged intestinal tissue resulting from various 
pathologies and treatments. 
RESULTS 
Early gut markers in definitive endoderm  
Since the embryonic gut tube is derived from endodermal cells, we assessed the potential 
usefulness of ESC-derived definitive endoderm for producing ISCs. Definitive endoderm 
originates during gastrulation from early mesendoderm, which is generated in response to nodal 
signaling emanating from the anterior region of the primitive streak. Activin A is a member of the 
TGF- β superfamily that has been shown to mimic nodal and promote definitive endoderm 
differentiation from ESCs in culture (Fig. 3.1A) 20,87. We assessed the effectiveness of activin A 
treatment of mouse ESCs under serum free conditions for generating definitive endoderm. As 
shown in Fig. 1C, expression of the definitive endoderm markers Cxcr4, Sox17, Foxa2, and Gsc 
were significantly increased following activin A treatment, whereas the stem cell markers Pou5f1 
and Nanog were both significantly decreased (Fig. 3.1B). To determine the potential of these cells 
to become intestinal epithelium, we determined the expression of a number of genes expressed in 
the early embryonic gut. Fig. 3.1D shows the expression levels of a series of gut transcription 
factors arranged in order of appearance during embryogenesis 91. Sox17, Foxa2, and Gata4 were 
expressed in the definitive endoderm, whereas Id2 was not. As discussed below, Id2 is activated 
later than the other markers (E9), possibly accounting for its lack of activation in the definitive 
endodermal cells 20,91. 
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 A number of genetic markers have been employed to identify adult ISCs. We assessed the 
expression level of four genes associated with the ISC for their activation following cell 
differentiation to definitive endoderm. We found that of the four genes tested, only Lgr5 increased 
following conversion to endoderm, whereas no significant change in Msi1, Ephb1, or Dclk1 
expression was observed (Fig. 3.1C). 
 To determine if human ESCs responded similarly to the activn A differentiation 
procedure, the human H9 ESC line was subjected to this protocol (Fig. 3.2A). As shown in Fig. 
3.2B, the Pou5f1 and Nanog stem cell markers were decreased upon conversion to definitive 
endoderm whereas all the definitive endoderm markers were activated (Fig. 3.2C). In addition, 
the gut transcription regulatory proteins were all increased except for Id2, suggesting a 
progression similar to that observed in the mouse stem cells (Fig. 3.2D). As in mESCs, the ISC 
marker Lgr5 was activated upon endodermal differentiation whereas the other ISC markers were 
unchanged (Fig. 3.2E). These data indicate that the human cells respond similarly to the mouse 
ESCs with regards to this endodermal differentiation pathway.  
Wnt stimulation of definitive endoderm 
 The ISC crypt is supported by mesenchymal cells that generate Wnt ligand, growth 
factors, and other signaling molecules that promote ISC survival, proliferation and differentiation 
86,92. We therefore determined the impact of fibroblast-conditioned medium on the definitive 
endoderm cells, using conditioned medium from control fibroblasts or transgenic fibroblasts 
expressing Wnt3A (Fig. 3.3A). When the gene expression pattern of the early gut markers was 
analyzed, it was found that expression of Sox17, Foxa2, and Gata4 was either maintained or 
slightly enhanced following treatment with Wnt3A containing conditioned medium (Fig. 3.3B). 
In addition, the conditioned medium treatment resulted in activation of the later gut marker Id2, 
with the Wnt3A-containing medium working more efficiently that the control medium (Fig. 
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3.3B).  To obtain further evidence for the generation of intestine-like endoderm, we determined 
the expression levels of Cdx2 and Fabp2, which are activated in the mouse at embryonic days 8.5 
and 15, respectively 80,89,93. Both markers were found to be activated to approximately the same 
level in control conditioned medium and Wnt3A conditioned medium (Fig. 3.3C). Since Fabp2 
expression indicates differentiation into an absorptive cell phenotype, we also checked whether 
cells within these bodies had the potential to differentiate into a secretory lineage. As shown in 
Fig. 3.3D, the Muc2 gene, which encodes a mucin protein, was expressed 4 days after Fabp2 is 
detected. The expression of Muc2 could be enhanced by treatment with the γ-secretase inhibitor, 
DAPM, which is consistent with Notch signaling limiting secretory cell differentiation in the 
embryoid bodies. 
 We next determined the influence of conditioned medium on the expression of the ISC 
markers. Lgr5, which was activated during the differentiation to definitive endoderm, was largely 
unchanged following exposure to conditioned medium (Fig. 3.3E). However, treatment with 
conditioned medium lead to the activation of three other marker genes associated with the stem 
cell compartment: Msi1, Epbh2, and Dclk1. Activation of Ephb2 expression was enhanced by the 
presence of Wnt3A whereas Msi1 and Dclk1 were not. 
Activation of mesoderm markers by conditioned medium 
  The developing gut features extensive crosstalk between the endoderm and mesoderm 
associated with the developing gut tube. We therefore performed a biomarker analysis to 
determine whether there was any indication of gut mesoderm development in the cultures. For 
this analysis we selected markers associated with the distal GI tract development in the mouse: 
Foxf2, Hlx, and Hoxd8 22,83,94,95. As shown in Fig. 3.3F, all three markers were activated by 
conditioned medium and all three were enhanced by the presence of Wnt3A. These data suggest 
the generation of both endodermal and mesodermal tissues in this differentiation protocol. 
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Gut body formation in Wnt3A treated definitive endoderm 
 Fig. 3.4A shows representative colonies of ESCs, definitive endoderm, and Wnt3A-
exposed definitive endoderm. A common change observed in the Wnt3A-treated endoderm was 
the formation of a distinct, phase-dark periphery. The structures formed were reminiscent of gut 
bodies previously reported to form from differentiating embryoid bodies 67,96. In addition, some of 
the bodies displayed periodic contractions, much like the peristaltic action associated with gut 
bodies (data not shown). This finding suggested the formation a smooth muscle component. To 
further study the structural characteristics of the spheroid bodies formed following Wnt3A 
stimulation, cells were fixed, sectioned, and analyzed by immunofluorescence. As shown in Fig. 
3.4B, the general gut transcription regulator Id2 stained most of the cells within the spheroids 91. 
In addition, some cells at the periphery of the spheroids were positive for smooth muscle actin, 
consistent with the inclusion of a mesodermal layer in these structures (Fig. 3.4C). 
A characteristic feature of intestinal epithelium is a gradient of β-catenin, with cells at the 
crypt base expressing higher levels relative to mature cells. The gut organoids generated in 
culture maintain a similar gradient, with higher β-catenin levels in cells at the periphery (Fig. 
3.5A). We also assessed locations of cell proliferation within the structures by staining with 
PCNA to determine if proliferative regions were structured as they are in the intestinal mucosa. 
Fig. 3.5B shows two common arrangements of cell proliferation, with proliferating cells clustered 
at the edges of the sphere (left panel) or with small clusters of proliferating cells within the sphere 
(right panel). Regions of cell proliferation can sometimes form small outcrops containing clusters 
of proliferating cells, reminiscent of the intestinal organoid cultures formed by Lgr5-positive cells 
isolated from the small intestine 23. The spheroid and out-cropping arrangements formed are 
shown as bright field images of unsectioned organoids (Fig. 3.5C). To determine how Lgr5 
expression related to regions of cell proliferation, immunostaining for Lgr5 and PCNA was 
performed. As shown in Fig. 3.5D, there are discreet regions of elevated Lgr5 expression, which 
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corresponded to regions of cell proliferation. Finally, to view the spatial relationship between 
zones of cell proliferation and cell differentiation, sectioned organoids were immunostained for 
PCNA and the goblet cell protein TFF3. Fig. 3.5E shows two representative crypt-like regions, 
with proliferating cells present at the base of the crypts and the red-punctuate TFF3 staining 
appearing in secretory vesicles of cells adopting goblet cell characteristics. This arrangement of 
cells is similar to that found in intestinal crypts. 
Introduction of definitive endoderm into the mouse colon 
 Since the definitive endoderm was found to express the Lgr5 stem cell marker, and could 
be introduced to express other genes associated with intestinal development, we determined 
whether these cells had the ability to associate with mouse intestinal mouse epithelium and 
assume a crypt-like structure. For these studies, mouse ESCs expressing GFP were introduced 
into the colon through the rectum of B6 mice that had been treated with DSS to denude portions 
of the epithelium, since this procedure has been shown to promote cancer cell association with the 
intestine 97. Twelve days after introduction of the cells, colons were isolated, fixed, and frozen. 
Frozen sections of rolled tissue were then prepared and checked microscopically for green 
fluorescent cells. A number of regions were observed in which isolated groups of green 
fluorescent cells were observed (Fig. 3.6A). In addition, a number of regions were identified in 
which GFP-labeled cells appeared to incorporate into crypts, primarily within the crypt base (Fig. 
3.6B). To determine if the incorporated cells were capable of proliferation, a serial section of a 
GFP-labeled crypt was analyzed for PCNA expression. PCNA expression was found to overlap 
with cells expressing GFP, indicating that donor cells within these crypts were proliferative (Fig. 
3.6C). To determine if cells within the incorporated crypts were capable of generating 
mucopolysaccharides, Alcian blue staining was performed on a serial section of a GFP-expressing 
crypt. This analysis indicated that cells within the GFP-labeled crypts were capable of expressing 
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mucin, consistent with an ability to differentiate toward a secretory cell lineage (Fig. 3.6D). 
DISCUSSION 
 The directed differentiation of pluripotent cells to an intestinal lineage could provide a 
valuable experimental system to address important issues in developmental biology. In addition, 
these cells may ultimately be useful for repairing intestinal mucosa damaged by inflammation, 
radiation, or chemotherapeutic agents. We therefore assessed the potential of definitive endoderm 
generated from ESCs to commit to an intestinal lineage. Stem cell-derived definitive endoderm 
expressed a series of transcriptional regulatory genes found in the endoderm of day 8.5 (E8.5) 
mouse embryos. Specifically, Sox17, Foxa2, and Gata4 are expressed in the endoderm, whereas 
Id2, which is activated at day 9 was not 91. At E9, the early gut tube is formed juxtaposed to 
visceral mesoderm. Further treatment of the stem-cell derived endoderm with fibroblast 
conditioned medium resulted in the appearance of the later embryonic markers Cdx2, Fabp2, and 
Muc2 98. In the mouse, Fabp2 is expressed most robustly in the jejunum but also appears in the 
duodenum and colon. The appearance of these markers in our differentiated cells suggests that 
stem-cell derived endoderm have the ability to generate intestinal epithelium. Additional evidence 
for the formation of intestinal epithelium comes from the analysis of cell proliferation and Lgr5 
expression; PCNA and Lgr5 expression co-localize to discreet regions of the organoids, forming 
structures reminiscent of intestinal crypts. Finally, the formation of functional intestinal 
epithelium is supported by the finding that the cells can associate with the intestinal mucosa of 
adult animals, and form crypt-like structures. 
 The intestinal epithelium is constantly turning over and stem cells present at the base of 
the intestinal crypts generate new cells to populate the tissue. Several biomarkers have been 
proposed to identify stem cells within the intestinal mucosa. In this study we examined the 
expression of four ISC markers: Msi1, EphB2, Dclk1, and Lgr5. Msi1, the mammalian homolog 
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of the Drosophila Musashi protein, was one of the first proposed ISC markers. Msi1 is expressed 
in mammalian neural progenitor stem cells where it plays a key role in regulating cell potency 
23,63,90,99–102. In the intestine, Msi1 is expressed in cells above the Paneth cells and within the crypt 
base 23,63,100. The second marker we examined was the Ephb2 ephrin receptor, which is likewise 
expressed by cells within the stem cell compartment where it plays an important role in 
promoting cell proliferation in the niche region 103. The third stem cell marker we examined, 
Dclk1, is expressed in a limited number of slowly dividing cells within the crypts 104,105. Isolated 
Dclk1 cells form gland-like structures in the flanks of athymic mice, supporting their epithelial 
progenitor capacity. Finally, the Lgr5 gene was originally identified as a Wnt-responsive gene 
expressed in columnar cells at the base of the intestinal crypts22. Lineage tracing experiments 
indicate that all epithelial cells within the crypt are derived from Lgr5-expressing cells. In 
addition, isolated Lgr5 positive cells can form crypt–villus organoids when cultured ex vivo 23. 
The precise relationship between cells expressing these different stem cell markers is not yet 
clear. One possibility is that they can all serve as stem cells under different conditions. Radiation-
induced apoptosis studies are consistent with the presence of multiple stem cell sources in the 
intestine, with up to 32 stem cells potentially serving as a crypt stem cells when necessary106–109. 
Whether the cells with differing sensitivity to radiation are distinct pools of cells, or whether they 
are inter-convertible, is also not presently clear. Our in vitro differentiation procedure shows that 
Lgr5 expression precedes that of the other stem cell markers. This finding is consistent with Lgr5 
serving to mark the most primitive cell type committed to an ISC lineage. We propose that the 
cells expressing the other stem cell markers are derived from these Lgr5 positive cells, and retain 
the ability to contribute to crypt development. The differentiation procedure we describe here 
should be particularly useful for determining the relationship between the cells expressing 
different ISC markers, and the signaling pathways involved in regulating stages in their 
development. 
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 ISC reside in a niche in which myofibroblasts generate Wnt and other growth regulatory 
factors to promote the survival and proliferation of the stem cells 84,88,97,98,110,111. Since Wnt 
signaling plays an important role in promoting cell proliferation in the intestine and colon, we 
initially reasoned that treatment of definitive endoderm with Wnt ligand would promote the 
expression of Lgr5 and the other stem cell markers. Interestingly, we found that Lgr5 was 
expressed in definitive endoderm prior to Wnt exposure. In addition, we found that fibroblast 
conditioned medium in the absence of Wnt3A was sufficient for inducing expression of the other 
ISC markers. In hindsight, this finding should not be too surprising given the fact that Wnt 
signaling in early development is “reversed”, with robust signaling occurring in the maturing villi 
(where it promotes differentiation), and little activity at the proliferating base 112. The requirement 
for Wnt signaling in promoting ISC proliferation and survival may therefore occur at a 
developmental time point later than what is modeled in our in vitro differentiation procedure. 
 Although expression of most of the intestinal epithelial markers was not stimulated by 
Wnt3A, all the mesodermal markers tested were. The mesoderm in these cultures may serve to 
guide the differentiation of the gut bodies, since the expression of the mesoderm markers 
corresponded with an increase in the number of gut bodies actively performing peristalsis. Our 
findings suggest that Wnt may play an important role in the development of mesenchymal 
component of the lower gut. It is well-established that the inhibition of Wnt signaling in early 
development leads to a shortened intestine, and this could result in part from deficiencies in the 
growth of the mesenchymal portion of the tissue 113,114. However, analysis of β-catenin activity in 
the mesoderm has failed to provide evidence of canonical Wnt signaling in this portion of the 
developing tissue 94. If Wnt signaling is important for the development of the splanchnic 
mesoderm in the lower GI tract, it is either occurring indirectly or it involves signaling through a 
non-canonical Wnt pathway. An indirect mechanism might be one in which Wnt activates the 
endoderm to express factors (such as hedgehog ligands) that promote the differentiation of the 
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mesoderm 94. The differentiation procedure described here should provide a tractable model that 
could generate important insight into the mechanism by which Wnt signaling stimulates the 
differentiation of mesoderm into distal-gut tissue. 
A potential clinical application of the differentiation procedure described here includes 
generating cells that can populate, protect, and restore damaged intestinal tissue. As predicted by 
their developmental potential when grown in culture, GFP-expressing, Lgr5-positive endoderm 
cells can associate with intestinal tissue and form crypt-like structures. These structures possess 
proliferating cells, and appear to include goblet cells. Whether these are fully functional crypts is 
not entirely clear. For instance, the GFP labeled cells appear to reside primarily at the crypt base, 
and we have not yet observed their extension to the surface of the tissue. In addition, the 
engraftment efficiency of these cells is low, with less than one incorporation event observed per 
animal (on average). Nonetheless, the ability of these cells to incorporate into the tissue is a first 
step towards the development of these cells for potential therapeutic uses. The practical value of 
cell-based therapies is supported by the recent finding that mesenchymal stem cells can promote 
repair of DSS-induced colonic ulceration 66,115,116. Providing both ISCs generated from ESCs or 
IPS cells, and mesenchymal stem cells to damaged tissue is likely to provide the most effective 
means of repairing damaged intestinal tissue. 
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Figure 3.1. Activin A induced definitive endoderm differentiation from mouse ESCs.  
(A) Schematic of the cell culture protocol used to induce mouse ESC differentiation into 
definitive endoderm. This protocol employed activin A (50 ng/mL) treatment in serum free 
differentiation medium (SFD). (B–E) Relative expression of mRNA markers in the definitive 
endoderm cells (DE) relative to the mESCs. The mean of triplicate experiments are shown 
(±standard error). (B) Decreased expression of pluripotency markers Pou5f1 and Nanog in DE. 
(C) Definitive endoderm markers were increased following the treatment scheme shown in 1A, 
relative to mESCs. (D) The expression of transcription factors in the digestive tract of mouse 
embryos, arranged in order of their appearance during mouse embryogenesis. Sox17, Foxa2, and 
Gata4 were significantly increased in expression, whereas Id2 was not. (E) Markers of adult ISCs 
were determined for their activation following the differentiation procedure. Lgr5 was the only 
ISCs marker activated in the definitive endoderm cells. All gene expression changes shown in this 
figure were statistically significant (p<0.01, Student’s t test), with the exception of Id2, Dclk1, 
Msi1, and Ephb2, which were unchanged. 
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Figure 3.2. Activin A induced definitive endoderm differentiation from human ESCs.  
(A) Schematic of the procedure employed to establish human definitive endoderm cells from H9 
hESCs. This protocol employed using activin A (100 ng/ml) and Wnt3A (25 ng/mL) in serum free 
differentiation medium (SFD) for 2 days, followed by 0.5% FBS and the PI3 kinase inhibitor 
LY294002 for 2 additional days. (B) Expression of pluripotency markers in the definitive 
endoderm cells (DE) relative to the ESCs. (C) Expression of definitive endoderm markers relative 
to the ESCs. (D) Expression of gut transcription factors in definitive endoderm cells relative 
ESCs, with the gut markers aligned according to their order of expression during embryonic 
development. (E) Expression of adult ISC markers following endoderm differentiation. All 
expression data are shown as the mean of triplicate experiments with the bars indicating the 
standard error. All gene expression changes shown were statistically significant (p<0.001, 
Student’s t test), with the exception of Id2, Msi1, and Ephb2, which were unchanged. 
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Figure 3.3. Conditioned medium induced differentiation from definitive endoderm.  
(A) Schematic of the culturing protocols employed to induce definitive endoderm to assume an 
intestinal lineage. Mouse definitive endoderm cells were treated with fibroblast conditioned 
medium (CM) or conditioned medium containing Wnt3A (CM+Wnt3A). (B) Expression of 
intestinal transcription factors following exposure of endoderm cells to conditioned medium or 
conditioned medium containing Wnt3A. (C) Expression of the posterior endoderm/gut markers, 
Fabp2 and Cdx2, following exposure of endoderm cells to conditioned medium or conditioned 
medium containing Wnt3A. (D) Expression of Muc2 in endoderm cells and endoderm cells 
treated with CM plus Wnt3A. In this experiment, endoderm cells were treated with CM for 8 days 
(instead of 4). In one culture, DAPM was included in the culture medium for the final 2 days. (E) 
Expression of the ISC markers following exposure of endoderm cells to conditioned medium or 
conditioned medium containing Wnt3A. (F) Expression of distal gut mesoderm markers 
following exposure of endoderm cells to conditioned medium or conditioned medium containing 
Wnt3A. All graphs show the mean of triplicate experiments (±standard error) with the expression 
levels normalized to that found in definitive endoderm. The indicated changes were statistically 
significant as determine by ANOVA (* p<0.01; ** p<0.001). 
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Figure 3.4. Evidence for intestinal organoid formation in Wnt3A treated definitive endoderm.  
(A) Representative phase contrast images of mESCs, definitive endoderm, and definitive 
endoderm treated with Wnt3A conditioned medium (Intestinal lineage). Note the distinctive, 
phase-dark periphery formed following treatment with Wnt3A. (B and C) Intestinal lineage cells 
were fixed and sectioned for immunofluorescent staining. The left panel of B shows staining for 
the general intestinal transcriptional regulator Id2. The corresponding DAPI-stained image is 
shown to the right. The left panel of C shows the results of immunostaining for smooth muscle 
actin. The corresponding DAPI-stained image is shown in the right panel. 
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Figure 3.5. β-catenin, PCNA and Lgr5 expression in the putative intestinal organoids.  
(A) β-catenin immunofluorescence of a sectioned organoid. The left panel shows the Cy3 staining 
for β-catenin and the right top panel shows the β-catenin staining (red) merged with the DAPI 
DNA staining (blue). (B) PCNA expression in two sectioned organoids. Immunostaining for 
PCNA is shown in red and the DAPI DNA staining is blue. (C) Bright field images of two 
representative organoids, with or without visible outcroppings. (D) Lgr5 immunofluorescence of 
two sectioned organoids. The upper panel shows the Cy3 staining for Lgr5 and the lower panel 
shows the Lgr5 staining (red) merged with PCNA staining (green). (E) Two crypt like regions 
from organoids were stained for PCNA (FITC/green) and TFF3 (Cy3/red). 
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Figure 3.6. Introduction of GFP-expressing definitive endoderm cells into the mouse colonic 
mucosa. Mouse ESCs were treated to generate definitive endoderm (as in Fig. 1A) and introduced 
transrectally into mice treated with DSS for 1 week. Twelve days after the cell introduction, 
colonic tissue was removed and prepared for frozen sectioning. (A) Image of a cluster of GFP-
expressing cells in the colon (blue is DAPI-stained DNA). (B) Sections of the mouse colon were 
GFP-expressing cells were found associated into a crypt. (C) Serial sections of the mouse colon 
with the left panel showing a section analyzed for GFP expression and the right panel showing 
immunostaining for PCNA expression. (D) Serial sections of the mouse colon with the left panel 
showing a section analyzed for GFP expression and the right panel showing Alcian blue staining 
for mucopolysaccharide production. 
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CHAPTER 4 
DEVELOPMENT OF INTESTINAL ORGANOIDS AS TISSUE SURROGATES FOR THE 
ANALYSIS OF STEM CELL DYNAMICS AND DIFFERTIATION  
 
INTRODUCTION 
The intestinal epithelium is a dynamic tissue in which stem cells positioned at the crypt 
base provide progeny cells that differentiate and perform critical tissue functions such as the 
secretion of mucous and anti-microbial defensins and the absorption of water and nutrients 11,12. 
Understanding the signaling pathways responsible for regulating the transition of stem cells from 
their multi-potent state into defined differentiation pathways could provide important insight into 
developing targeted treatments that maintain proper tissue structure and function.    
Lineage tracing experiments have revealed the existence of multiple stem cell 
populations within the intestinal and colonic crypts. Using this approach it was first shown that 
Lgr5-expressing cells are positioned at the crypt base and that progeny of these cells go on to 
become secretory and absorptive lineage cells 22,117. Lgr5-expressing cells are characterized by 
their columnar morphology and their relatively high rate of proliferation. They are located 
between Paneth cells in the small intestine, with these latter cells playing an important role in 
maintaining stem cell viability 118,119. In addition to the rapidly cycling Lgr5 positive cells, a 
slower cycling population of stem cells also exists. These cells are at position +4 relative to the 
crypt base and were initially indentified as DNA label-retaining cells 120. This population of cells 
expresses Tert, Hopx and Lrig1, and lineage tracing shows that they also give rise to all the cell 
types that constitute the intestinal epithelium 17,113–115. Present data point to a potential hierarchal 
relationship between the ISC populations with Tert/Hpox/Lrig1 +4 cells providing a stable source 
of slow-dividing cells and the more rapidly cycling Lgr5 pool serving as the primary source of 
cells under most circumstances17,21. Interestingly, inter-conversion between Lgr5 and +4 cells has 
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been detected, suggesting that the tissue can withdraw cells from the stable +4 pool when needed, 
and replenish the +4 pool as required 122.  Whether +4 cells and Lgr5-expressing cells are the 
exclusive cell sources in the small intestine and colon is not entirely clear. Dclk1-expressing cells 
have interesting properties in that they function as mature Tuft cells in the tissue, but they also 
have seed the formation of glandular structures following transplantation20,76,124. Dclk1 may 
therefore mark a differentiated cell type that can revert to a stem cell under some circumstances. 
Interestingly, in situ hybridization experiments have indicated that Dclk1 cells may also express 
the Lgr5 stem cell marker 78. 
The signals that maintain the stem cell population within the intestines are provided by 
cells at the base of the crypts. Myofibroblasts have long been recognized as important 
components of the niche environment and provide an important source of Wnt to stimulate stem 
cell proliferation. Epithelial cells and other cell types likewise express Wnt and other signals to 
establish the niche. Present data support a model in which a range of positively and negatively 
acting signals control ISC potency and the transition to mature cells as they move away from the 
niche region 88,115. Wnt proteins and associated agonists such as R-spondin promote division and 
suppress differentiation at the base of the crypt, while Wnt inhibitors such as Dkk1 limit the 
expanse of the Wnt signal 96,125. Likewise, differentiation is signaled by BMP expressed higher in 
the tissue, with this differentiation signal regulated by counteracting inhibitors such as Noggin 
and Gremlin 126–128. Other important signals within the milieu of the tissue include EGF and EphB 
which stimulate proliferation, and hedgehog ligands that promote differentiation 103,129–132. Notch 
signaling plays a critical role in regulating the dynamics of intestinal tissue. Evidence has been 
obtained that Notch signaling through adjacent cell-cell interactions maintains both stem cell 
potency and differentiation to an absorptive lineage (columnar epithelial cells and enterocytes) at 
the expense of secretory cells (goblet, enteroendocrine and Paneth cells) 52. Key to this activity is 
the Notch target gene Hes1. Hes1 is a basic-helix-loop-helix (bHLH) protein that suppresses 
Atoh1 expression and activity 133. Atoh1 is likewise a bHLH protein that regulates gene 
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transcription and stimulates the differentiation of secretory cells in the small and large intestine 
134. Studying the impact of Notch signaling on intestinal tissue has been facilitated by the 
availability of specific γ-secretase inhibitors. These inhibitors prevent cleavage of the Notch 
receptor following ligand engagement and thereby the generation of the Notch intercellular 
domain (NICD) proteolytic fragment responsible for altering expression of target genes. 
Treatment of mice with γ-secretase inhibitors promotes the formation of goblet and other 
secretory cells 135,136. This potent differentiation function can halt the growth of intestinal tumors 
in ApcMin/+ mice by inducing tumor cells to terminally differentiate into goblet cells. In normal 
mucosa, γ-secretase inhibitors can increase goblet cell differentiation and mucous production to 
protect intestinal tissue from DSS-induced inflammation. These findings exemplify how 
understanding the differentiation pathways in the mucosa can be utilized for developing novel 
approaches for treating disease. 
Our understanding of the signaling pathways involved in regulating cell dynamics in the 
intestines comes largely from studying mouse models and transformed cell lines. Recently, 
technology has been developed that enable the growth of intestinal organoids, either from isolated 
ISCs or following differentiation of ESCs 8,9. These organoids possess both stem cell and 
differentiated cell components that are organized much like they are in the intact mucosa. These 
organoids open up the opportunity for the rapid analysis of biological agents and small molecules 
for their ability to alter the growth and differentiation of intestinal cells, which in turn could result 
in the uncovering of new signaling mechanisms and novel pharmacological targets. ESC-derived 
organoids have some potential advantages, including the ability to generate large numbers of 
organoids from ESCs of wide range of genetic backgrounds. In this report we characterize the cell 
types that constitute IOs obtained from mouse ESCs following differentiation conditions 
described by ourselves and others. We find that these organoids are enriched in ISCs and that they 
include both Tert+ and Lgr5+ stem cells. Although Atoh1 and Hes1 expressing cells are present in 
these populations, fully differentiated cells constitute only a few percent of the organoid. Long-
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term culturing of the organoids showed that cell differentiation was sensitive to culture 
conditions, whereas the stem cell populations remained relatively stable. Finally, our data show 
that organoids generated from ApcMin/+ mice have a reduced capacity to produce Atoh1-expressing 
cells, similar to what is observed in intestinal tissue.  From these data we propose that IOs are 
useful for modeling ISCs and early stages of their differentiation. They may be particularly useful 
for developing approaches that suppress the progression of mutated intestinal cells to malignancy.   
RESULTS 
Cell types in ESC-derived definitive endoderm and intestinal organoids 
Conditions have been described for generating IOs from human or mouse ESCs and 
IPSCs 8–10. These approaches entail an initial enrichment for definitive endoderm (DE), using 
activin A to simulate embryonic nodal signaling, followed by a posteriorization of the resulting 
endoderm by treatment with Wnt ligand. As previously reported, RNA analysis from organoids 
generated in this manner express the ISC genes Lgr5 and Tert, as well as differentiation regulators 
and terminal differentiation markers. Figure 4.1A shows a schematic of the differentiation 
procedure, with Wnt3a conditioned medium used to induce intestinal differentiation of DE, as 
indicated by increased expression of the mucin gene Muc2 and the intestinal fatty acid binding 
protein, Fabp2 (Figure 4.1B). Under this culture condition, expression of the stem cell markers 
Lgr5 and Tert and the differentiation regulators Atoh1 and Hes1 were relatively unchanged in the 
endoderm to organoid transition (Figure 4.1B). 
To better understand the composition of the DE and IOs, cells were dispersed, sorted by 
the flow cytometry and assayed individually for gene expression. As a comparison, cells were 
stripped from the colonic mucosa and assayed in parallel.  We have previously reported that this 
approach generates an accurate representation of gene expression profiles within the cell 
population, based on reconstruction of bulk expression levels. As shown in Figure 4.1C, cells in 
the DE and organoids were much more likely to express a stem cell marker, relative to those 
obtained from the colon (e.g., Lgr5, Tert and Msi1). Conversely, cells stripped from the colon 
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more frequently expressed genes associated with secretory or absorptive cell lineages, Muc2 and 
Fabp2, respectively. In general, these data indicate that the 10 day old organoids are enriched in 
stem cells and cells that inhabit the crypt base. Although organoids do express Muc2 and Fabp2 
mRNA, we estimate they these cells constitute less than one percent of the total population of the 
organoids maintained under these growth conditions.  
Cluster analysis of stem cell markers 
To better characterize the cells in the organoids expressing stem cell markers, individual 
RNA expression profiles were examined. As shown in Figure 4.2, Msi1 was broadly expressed in 
both the DE and the organoids. The expression of Tert and Lgr5 was more limited, consistent with 
these mRNAs serving as more selective markers of ISCs. Importantly, the Lgr5 and Tert 
expressing cells resolved into two distinct subpopulations, consistent with the two ISC 
populations observed in intestinal tissue 17,21,77. Dclk1 resolved into an independent cluster, but 
was also found to be co-expressed with Lgr5. The co-expression of Dclk1 with Lgr5 has been 
reported in intestinal mucosa 77. This latter finding suggests that there may be distinct types of 
Dclk1 expressing cells in the DE and organoids. 
Structural organization of intestinal organoids 
We and others have reported that intestinal organoids assemble into structures that are 
organized in a manner reminiscent of the intestinal mucosa. Figure 4.3 shows the 
immunofluorescent staining of DE and organoids for active β-catenin, Atoh1 and Dclk1. Colon 
tissue was stained as a control. Both the DE and the IOs stained for active β-catenin. In the 
smaller DE, staining was relatively uniform throughout the embryoid bodies. Active β-catenin in 
the organoids was somewhat more structured, with staining most intense at the periphery or 
within small invaginations. These regions of the organoid resemble the crypt base, which likewise 
stains intensely for active β-catenin. Also shown in Figure 4.3 is the Atoh1 staining of the 
intestine, DE and organoids. Atoh1 staining of the tissue reveals Atoh1 expressing cells scattered 
throughout the epithelium typically positioned above the crypt base where it regulates the 
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commitment to a secretory cell lineage 134. Atoh1 cells were found to be rare in the DE, but more 
frequently apparent in the organoids (Figure 4.3). In the organoids, Atoh1 expressing cells were 
positioned towards the center of the bodies, in contrast to the cells expressing active β-catenin 
usually at the periphery.        
DE and IOs were examined for the positioning of Dclk1 expressing cells. In the colonic 
epithelium, Dclk1-expressing cells are found at variable positions with several present in each 
crypt (Figure 4.3). These cells can usually be identified as Tuft cells, which are cells of the 
secretory lineage 76,124. Analysis of Dclk1-expressing cells in the DE shows that these cells were 
positioned almost exclusively at the surface of the embryoid bodies (Figure 4.3). Although 
Dcamk1-expressing cells were most abundant in the DE, they could also be detected in the 
organoids where they were likewise positioned at the surface.  
Effect of differentiation conditions on organoid cell composition 
The IOs at day 10 showed expression of terminal differentiation markers Muc2 and 
Fabp2 in the bulk RNA, but no cells were detected in the single cell analysis. These data 
indicated that the number of mature cells in the population was relatively small. To determine 
whether the number of mature cells increased with longer periods of time, culture conditions were 
extended to days 16 and 27. In addition, we compared two differentiation protocols 8,9 (Figure 
4.4A). DE was generated as usual for both protocols. In protocol 1, posteriorization of the DE 
was achieved using medium conditioned by a mouse fibroblast line expressing a Wnt3a transgene 
(providing the requisite Wnt and FGF signals; Figure 4.4A).  In protocol 2, DE was treated with 
recombinant FGF and Wnt3a for 4 days, followed by culturing in medium used to maintain IOs 
(which includes R-spondin, EGF and Noggin; Figure 4.4A). Single cells were isolated on days 16 
and 27 of these protocols and analyzed for mRNA expression as in Figure 4.1C. As shown in 
Figures 4.4B and 4.4C, both differentiation procedures lead to a drop in the number of cells 
expressing Msi1. In addition, Muc2 and Fabp2 expressing cells were now detected, although 
these cells still constituted only a small percent of the total.  
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To determine how the stem cells were affected by the longer-term culturing in the two 
media, gene expression profiles were used to cluster the cells expressing stem cell markers. In 
general, the number of cells expressing an ISC marker did not change dramatically, regardless of 
time or culture conditions (Figure 4.5) , indicating that the organoids were still populated mostly 
by crypt-like cells. Discreet populations of Lgr5 and Tert positive cells were still apparent at days 
16 and 27. One notable shift in the clusters was a trend to resolution by day 27, at which time 
Tert-expressing cells under both conditions were largely Msi1-resolved almost entirely from the 
Lgr5 subpopulation by day 27. How these changes effect stem cell potency is however not known 
negative (whereas many Lgr5 positive cells continued to co-express Msi1). In addition, Dclk1 
expressing cells, but suggest that the stem cells in the organoids mature over time.  
The differentiation regulators Hes1 and Atoh1 control the alternative differentiation 
pathways to secretory or absorptive cell 52,134. Both Hes1 and Atoh1 were variably expressed with 
time under both culturing conditions. Notably, however, the expression of these two genes was 
inversely correlated; an increase in one was accompanied by a decrease in the other (Figure 4.4B-
C). This finding is consistent with the repressive activity of Hes1 on Atoh1 expression 137. The 
apparent oscillation in Hes1 and Atoh1 expression may be related to the presence of regulatory 
feedback pathways in the organoids. 
Sensitivity of organoids to long term culture conditions  
To determine if the culture conditions could affect differentiation trajectory of the 
organoids, we maintained organoids in Wnt conditioned medium for 47 days, at which time RNA 
was isolated and analyzed for the expression of the secretory cell marker Muc2 and the absorptive 
cell marker Fabp2 (Figure 4.6A).  Interestingly, organoids maintained in IOM medium expressed 
higher levels of Muc2 whereas those in CM Wnt expressed more Fabp2. In addition, Alcian blue 
staining of the IOM organoids indicated mucin production (Figure 4.6B), whereas CM Wnt 
cultured organoids were negative for Alcian blue staining (not shown). These data demonstrate 
that the cellular differentiation fate within the organoids is sensitive to the growth medium 
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conditions, indicating that the organoids can be employed for studying agents that impact 
differentiation.  
Effect of genetic background and intestinal organoid characteristics 
To determine whether the intestinal organoid system is a suitable model for studying 
initiated intestinal mucosa, we generated organoids from ESCs from the cancer-prone ApcMin/+ 
mouse strain. Although tumor formation in these mice requires loss of the wild type Apc allele, 
heterozygous tissue shows a number of phenotypic changes, including a reduction in Atoh1 
expression and a decrease in the proportion of secretory cells within the tissue. We subjected to 
ApcMin/+ ESCs to the differentiation protocol using protocol 2 (Figure 4.4A), and determined the 
impact of Apc heterozygosity on mRNA expression in the organoids at days 10, 16 and 27. As 
shown in Figure 7A, the most dramatic change observed was a reduction of Atoh1 mRNA 
expression in the heterozygote organoids. Single cell analysis showed that the reduced level of 
Atoh1 mRNA expression corresponded to a reduced number of Atoh1-expressing cells (Figure 
4.8A). The reduction in Atoh1 expression was in contrast to the number of Hes1-expressing cells, 
which was largely unchanged (Figure 4.8A). Figure 8B shows representative images of Atoh1 
and β-catenin staining of wild type and ApcMin/+ organoids; the number of Atoh1 expression cells 
was lower in the ApcMin/+ organoids, whereas β-catenin staining which was similar. Consistent 
with our findings, the number of cells expressing Atoh1 has been reported to be reduced in the 
intestines of Apc heterozygote mutants. 
Examination of stem cell marker expression showed that, like the wild type organoids, 
cells in the ApcMin/+ organoids can be resolved into distinct Lgr5 and Tert expressing populations. 
The number of Lgr5-expressing cells was higher in the ApcMin/+ organoids relative to wild type 
organoids cultured under the same conditions (compare to Figure 4.5), but this difference was not 
statistically significant. The expression Lgr5 and Tert in the bulk mRNA was similar for both wild 
type and ApcMin/+ organoids (Figure 4.7A). The Apc mutation does not appear to disturb the 
resolution of the stem cells into their distinct populations, and they appear in the organoids in 
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roughly the same numbers. 
DISCUSSION 
As our understanding of tissue stem cell niches improves, increasingly sophisticated cell 
culture systems are being developed that can maintain adult stem cells in vitro. This is true for 
adult stem cells derived from the intestinal. Methods have also been described for deriving cells 
with ISC properties from mouse or human ESCs and IPSCs 8–10. These protocols involve the 
differentiation of cells to definitive endoderm, and then treating with Wnt and FGF source. Under 
a number of different described culture conditions, the isolated stem cells undergo their normal 
differentiation program and form organoids that maintain some of the structural characteristics of 
intestinal tissue. Whether prepared from adult ISCs or ESCs, IOs can be maintained in culture for 
prolonged periods of time, a process facilitated by the availability of recombinant and purified 
developmental signaling proteins, such as Wnt and R-spondin, which supports the survival and 
expansion of the ISCs within the organoids 96. IOs may provide a source of ISCs to repair 
intestinal tissue damaged by chronic inflammation, infection or radiation.  
In addition for use in tissue repair, organoids may also be useful as tissue surrogates for 
studying aspects of intestinal cell proliferation and survival and may also generate insight into 
pathologies associated with dysfunction of the intestinal epithelium.  It has recently been reported 
that intestinal organoids developed from human stem cells supported the replication of rotavirus 
isolates directly from stool samples, demonstrating their potential usefulness for studying 
gastrointestinal viruses 138. The application of organoids from the intestine could even be useful 
for the screening of small molecule libraries or siRNA/shRNA reagents to gain novel insight into 
intestinal cell biology and the signaling pathways that control their growth and differentiation. 
However, applying IOs as tissue surrogates requires a detailed knowledge of their composition 
under different culture conditions. This is particularly true for ESC-derived organoids; although 
the ability to expand and genetically manipulate ESCs provides advantages over tissue-isolated 
stem cells, it is not entirely clear how their composition related to the composition of intestinal 
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mucosa. For this reason we performed a detailed characterization IOs from mouse ESCs under a 
number of different growth conditions. We were particularly interested in determining which 
culture conditions were well-suited for analyzing ISCs and their commitment to an absorptive or 
secretory lineage. The data from our analysis is consistent with IOs under these conditions being 
enriched for ISCs (relative to the intestinal mucosa). Our data indicate that Lgr5 or Tert 
expressing cells constitute a few percent of the cells in the colonic epithelium. In contrast, twenty 
to thirty percent of the cells in our IOs express Lgr5 or Tert, two of the more discriminating ISC 
markers. Importantly, the Lgr5 and Tert expressing cells could be resolved into two distinct 
populations, similar to the intestinal mucosa 21,77,78 . The enrichment in ISCs is likely due to the 
relatively high levels of Wnt, R-spondin and other stem cell niche factors present in the medium. 
In addition to the stem cells, the organoids also include cells that express Atoh1, which regulates 
secretory cell differentiation. In the intestinal mucosa, Atoh1 expressing cells are positioned 
approximately half way up the crypt. In the organoids generated here, they usually are positioned 
at the center of the organoids. These data suggest the organoids generated in our studies resemble 
the crypt extending up to the Atoh1 expressing cells, and probably not much further given the low 
numbers of Muc2 and Fabp2 expressing cells identified. This model therefore is suitable for 
studying ISCs and early events in the differentiation process.   
Intestinal tissue at risk for cancer development, whether it is in the small intestine or 
colon, is frequently preceded by an expansion of the proliferative zone of the crypt with 
alterations in the execution of differentiation programs. ISC positioning within the crypts may 
also be affected. In the majority of colon cancers, a truncating mutation in the Apc gene is among 
the earliest genetic change. Although mutation in one of the Apc genes does not result in the 
formation of a neoplasm, intestinal cells change is a number of ways. One change that may be 
particularly amenable for study in the organoid system is the reduced Atoh1 expression. 
Specifically, Apc+/- have a reduced frequency of Atoh1-expressing cells in the small intestinal 
crypts, and as a result show a lower level expression of genes associated with a secretory cell 
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phenotype. This phenotype is reproduced in the IO system, as Apc+/- organoids have a reduced 
number of Atoh1 expressing cells. The mechanism linking Apc heterozygosity and Atoh1 
expression is not known, but could involve changes in Wnt or Notch signaling. The reduced 
expression of Atoh1 could serve to promote cancer development by suppressing an important 
growth-regulating differentiation pathway, or by rendering the tissue more susceptible to 
inflammation due to a reduced production of mucus and other anti-microbial defenses. It has been 
reported that enhancement of Atoh1 expression and secretory cell differentiation with Notch 
pathway suppressing γ-secretase inhibitors can reduce inflammation and intestinal cancer 
development in the mouse. The organoid system appears to be well-suited for studying this 
differentiation event in more detail, and potentially for identifying novel compounds that can 
promote Atoh1 expression. Other phenotypes associated with Apc heterozygosity includes mitotic 
spindle defects and shifts in metabolism. Although we have not examined these other changes in 
detail, it is possible that the organoid system could be useful for studying these alterations as well.        
One advantage of the organoid system as a tissue surrogate is that organoids can be 
developed from both human and mouse stem cells. As discussed above, IOs have been generated 
from human ESCs, IPSCs and adult stem cells. Although the human organoids will be invaluable 
for studying individual risk factors for cancer and IBD, we have chosen to focus on the mouse 
system for a number of reasons. One important advantage of the mouse system is the ability to 
generate IOs with precisely defined genetic defects so that mutated and wild-type organoids can 
be directly compared. This should give us the opportunity to determine how signaling and gene 
expression defects in the mutant organoids might be corrected. In the case of Atoh1 expression 
and secretory cell differentiation, the identification of nutritional agents and/or small molecules 
that can selectively enhance Atoh1 in the Apc heterozygote organoids could have 
chemopreventive value. Any agents identified in the mouse organoid system could then be 
directly tested in the mouse for cancer prevention properties and screened for general 
effectiveness in a panel of human IOs (derived for example from FAP patients). Although our 
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work here is focused on Apc mutant organoids, other cancer-related mutations could be similarly 
analyzed.   
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Figure 4.1. A) Flow diagram of differentiation procedure. Mouse ESCs were detached from 
fibroblasts on day 0 and grown as embryoid bodies in the presence of activin A to day 6. On day 
6, the resulting definitive endoderm was transferred to medium containing Wnt3a and allowed to 
further progress until day 10. B) Gene expression analysis at days 6 and 10. RNA was isolated 
from definitive endoderm (DE) or intestinal organoid cultures (IO) and analyzed for the 
expression of Lgr5, Tert, Atoh1, Hes1, Muc2 and Fabp2 by quantitative PCR. Values shown are 
relative to the expression in definitive endoderm. Expression of the differentiation markers Fabp2 
and Muc2 was significantly increased in the organoids (p < 0.01, Students t test). C) Single cell 
analysis of RNA expression. Cells from definitive endoderm and intestinal organoids were 
dispersed into single cells and sorted by flow cytometry. Cells from the colonic epithelium were 
likewise dispersed into single cells and sorted following EDTA stripping. Approximately 96 cells 
were analyzed in each sample. Cells in intestinal organoids were found to express Dclk1, Lgr5, 
Tert, Msi1 and Hes1 at a significantly greater frequency than the cells in the organoids, whereas 
the expression of Atoh1, Muc2 and Fabp2 was less frequent (p < 0.005; Fisher’s exact test). 
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Figure 4.2. Cell clustering based on stem cell marker expression.  
Hierarchical clustering of cell types was performed using JMP analysis software. Single-cell 
expression values (dCT*) range from blue (not detected) to red (highly expressed). Of the total 
number of cells expressing Lgr5 and Tert in the definitive endoderm, only two co-expressed these 
markers (p = 0.011, Chi-square test). For the intestinal organoids, none of the cells co-expressed 
Tert and Lgr5 (p = 0.017).   
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Figure 4.3.  Expression of β-catenin, Atoh1 and Dclk1 in colonic mucosa, definitive endoderm 
and intestinal organoids.  
Colon tissue, DE and organoids were fixed, sectioned and immunostained for the indicated 
protein markers using Cy3 β-catenin and Dclk1) or FITC (Atoh1) conjugated secondary 
antibodies. DAPI staining was performed to reveal the presence of the nuclei. 
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Figure 4.4. Effect of differentiation conditions on organoid cell composition. 
A) Protocols used to generate intestinal organoids. In both protocols, activin A was employed to 
enrich cultures in definitive endoderm. In protocol 1, cells were switched to medium conditioned 
with Wnt3a-expressing mouse L cells (Wnt CM). In protocol 2, cells were treated with 
recombinant Wnt3a and FGF until day 10, and then switched to intestinal organoid medium 
(IOM) containing R-spondin (Rs), EGF and noggin (Ngn) for the remaining time period. 
Individual cells were isolated on days 16 and 27 and processed for RNA analysis. B and C) Single 
cell transcript analysis of organoids generated by protocols 1 and 2. Organoids were dispersed 
and sorted into individual cells by flow cytometry. Each cell was examined for the transcripts 
shown by RT-PCR using the Taqman assay. The percentage of cells expressing the transcripts 
under the different conditions is shown. Data from epithelial cells stripped from the colon are 
shown for comparison. DE is the definitive endoderm, IO_D16 and IO_D27 are cells from day 16 
and day 27 organoids, respectively. Gene expression changes of interest include a significant drop 
in Msi1 expression at day 27, relative to definitive endoderm, under both medium conditions (p < 
0.001, Fisher’s exact test). However, the number of Msi1 expressing cells still remained 
significantly higher in the organoids relative to the colon (p < 0.005). There were more Lgr5 and 
Tert expressing cells in the organoids relative to the colon (p < 0.05), although this difference was 
not significant for Lgr5 in Wnt CM medium conditions. The number of cells expressing the 
terminal differentiation markers Muc2 and Fabp2 remained significantly lower in the organoids 
relative to the colon (p < 0.0001 and p < 0.05), respectively.  
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Figure 4.5. Cell clustering based on stem cell marker expression profiles of day 16 and day 27 
intestinal organoids generated by protocols 1 and 2 (Figure 4A).  
Hierarchical clustering of cell types was performed using JMP analysis software. Single-cell 
expression values (dCT*) range from blue (not detected) to red (highly expressed). The resolution 
of Lgr5 and Tert expressing cells into two distinct populations continued to be apparent for the 
Wnt CM and IOM conditions (p < 0.05 and p < 0.001, respectively). A trend to the resolution of 
Msi1 and Tert was also observed, as was a statistically significant separation of Dclk1 and Lgr5 
expressing cells in IOM medium at day 27 (p < 0.05). 
 
 
 
 59 
 
Figure 4.6. Sensitivity of organoids to long term culture conditions  
A) Influence of culture conditions on long-term organoid differentiation. Bulk RNA was prepared 
from organoids cultured under protocol 1 or protocol 2 conditions until days 16, 27 or 46, and 
then analyzed for Muc 2 or Fabp2 by RT-PCR. At day 46, the expression of Muc2 in the IOM 
cultured organoids was significantly higher than that found in Wnt CM organoids (p < 0.001; 
ANOVA). At 27 and 46 days, the Wnt CM organoids expressed more Fabp2 (p < 0.001). B) H&E 
and Alcian blue staining of organoids from protocol 2/IOM conditions. 
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Figure 4.7. Comparison of intestinal organoids generated from wild-type or ApcMin/+ intestinal 
organoids. Organoids were generated using protocol 2 (with maintenance in IOM medium). Bulk 
RNA and single cell transcript profiling was then performed. A) The RNA expression levels from 
wild type (WT) and ApcMin/+  (MIN) organoids, analyzed on the indicated days (in triplicate). 
Values shown are relative to expression levels in wild type definitive endoderm. The wild type 
organoids expressed significantly higher levels of Dclk1 and Atoh1, relative to the ApcMin/+ 
organoids (p < 0.005; ANOVA). B) Cell clustering by stem cell marker expression. Individualized 
cells from the ApcMin/+ organoids were analyzed for stem cell marker expression with the data 
clustered using JMP software. As with the wild type organoids, Tert and Lgr5 expressing cells 
existed as discreet subpopulations (p < 0.05). 
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Figure 4.8. Effect of genetic background and intestinal organoid characteristics 
A) Frequency of Atoh1-expressing cells in wild type and ApcMin/+ organoids. Organoids from wild 
type and ApcMin/+ ESCs were generated using protocol 2, and at day 16 cells were dispsersed for 
single cell analysis. The number of Atoh1 and Hes1 expressing cells in the culture were 
enumerated. There are significantly fewer Atoh1 expressing cells in the ApcMin/+ intestinal 
organoids relative to the wild type organoids (p < 0.001; Fisher’s exact test). B) ApcMin/+ and wild 
type intestinal organoids were analyzed for Atoh1 and β-catenin expression by 
immunofluorescence.  
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CHAPTER 5 
CONCLUSIONS 
The mammalian intestine is lined with a single layer of epithelial cells with a rapid cell 
turnover rate. Renewal of the epithelium depends on the ISCs residing in the base of crypts. The 
ISCs give rise to the transit-amplification cells, then migrate up to terminally differentiate into the 
secretory cells including goblet cells and enteroendocrine cells or absorptive enterocytes.  This 
high cell turnover of intestine epithelium makes it a very attractive system for the study of 
developmental biology and regenerative biology. 
 Recently, we and others have focused on developing multi-cellular structures called 
intestinal organoids. These IOs, derived from ESCs, induced pluripotent stem cells and adult ISCs 
that can be cultured and grown quickly in a defined medium system and resemble in vivo 
intestinal crypts, both in structure and developmental processes.  In the studies described within 
this thesis, I assessed the potential of differentiating ESCs to commit to an intestinal lineage using 
a two-step differentiation protocol. In the first step of this procedure, the definitive endoderm was 
generated from ESCs under the induction of Activin A. By the end of this step, the definitive 
endodeerm cells expressed not only definitive endoderm markers as expected, but also the ISC 
marker Lgr5 expression. The potential of definitive endoderm cells for repairing damaged 
intestinal tissue was then evaluated by transferring definitive endoderm cells into DSS-damaged 
colon of mice. The definitive endoderm cells could engraft into damaged colonic tissue, 
proliferate to form crypt-like structures and differentiate to intestinal epithelium. In the second 
step of our protocol, the definitive endoderm was treated with fibroblast-conditioned medium 
containing Wnt3a to generate intestinal organoids. By the end of this step, the definitive 
endoderm cells form crypt-like structures and activate expression of differentiation markers 
Fabp2, Muc2 and Tff3. Interestingly, enriched Lgr5 expressing cells were clustered in the 
intestinal organoids indicating the generation of a niche-like region of the organoid.  
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 Further characterization of the cell types that constitute intestinal orgaoids was performed 
using the two-step protocol under different culture conditions with different sources of Wnt and 
FGF. Single cell RNA analysis from organoids generated under these culture conditions showed 
that both Lgr5 and Tert expressing cells were found in the intestinal organoids, but resolved into 
two distinct subpopulations; consistent with the two ISC populations observed in intestinal tissue. 
Distinct types of Dclk1 expressing cells were also found in the DE and organoids; one resolved 
into a distinct group, and the other co-expressed Lgr5. Furthermore, cells expressing the 
differentiation markers Atoh1 and Hes1 were present in the organoids, but cells expressing 
mature intestinal cell markers Fabp2 and Muc2 were rare, indicating that the organoids were 
largely crypt-like. Finally, organoids generated from ESCs from the cancer-prone ApcMin/+ mouse 
strain were utilized to determine whether the IOs system is a suitable model for studying initiated 
intestinal mucosa. Bulk RNA analysis, single cell analysis, and immunostaining for Atoh1 
showed that organoids generated from ApcMin/+ mice have a reduced capacity to produce Atoh1-
expressing cells compared with organoids from normal ESCs; consistent with what was observed 
in intestinal tissue. This finding indicates that at least one of the phenotypes associated with this 
early cancer mutation is reproduced in the organoids.     
Future directions 
The gene expression profiles of IOs provide the evidence that the IOs from ESCs closely 
resemble cells positioned at the base of the crypt of the ileum and colon. The ease of 
manipulation, relatively fast growth rate, and cost savings of IOs make it possible to use our two-
step protocol to generate IOs for a range of applications including high-throughput screening for 
the study of developmental biology of intestine, regenerative medicine, and drug discovery. In 
particular, they may be useful for studying early colorectal cancer progression, cell signaling 
associated with inflammatory diseases, and developing novel therapies or preventive agents for 
diseases. The work described in this thesis focused on the development and characterization of 
the mouse IOs system. Given this focus on technology development, it outlines how these 
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organoids could be used to address important issues in colorectal cancer research.    
According to the American Cancer Society, colorectal cancer (CRC) is the third most 
common cause of cancer related deaths in the United States. About 50-85 percent of colorectal 
cancer begins as precancerous polyps, then progress through a series of morphological stages, 
which associated with some gene changes. Mutations on genes involved in colorectal cancer 
progression include APC/β-catenin, K-RAS, DCC, SMAD4, SMAD2, p53, and other changes 
that drive normal epithelium to metastasis 139. Researchers focus on the study of gene function in 
this multistage progression using the transgenic approaches, normally through transgenic mouse 
models. However, generating and maintaining such animal models is laborious, costly, and time-
consuming. An advantage of the organoid system is that organoids can be genetically manipulated 
to recapitulate different stages of cancer progression. For example, mutation in one of the APC 
loci is a very early step in colon cancer development, followed by the loss of the second loci. 
However, the mechanism by which the second locus is lost is unclear. It has been proposed that 
truncation in the APC gene will interfere with normal mitotic processes due to its dominant 
negative impact on microtubule 140,141. The effect of the truncating APC mutation on microtubules 
is independent of its role in β-catenin regulation. The defects in microtubule regulation at 
centrosomes and kinetochores lead to spindle abnormality, subsequently initiating chromosome 
instability (CIN) in a dominant manner, and ultimately initial colorectal cancer progression 142. 
SMC1L1, CSPG6, STAG3 are identified to be homologs of yeast genes that regulates sister 
chromatid cohesion. Somatic mutations in these genes result defective sister chromatid cohesion, 
thus cause CIN in human colorectal cancers 143. Gene knockdown of these genes can be 
performed by transfecting siRNAs into normal or ApcMin/+ ESC-derived organoids. The 
genetically organoids could then be screened to determine the extent to which loss of 
heterozygosity (LOH) is affected. This approach could facilitate the rapid analysis of how a range 
of mitotic regulating factors impact the rate of LOH in cells with a truncated APC.    
Earlier studies have suggested that reactive oxygen species (ROS) may play important 
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roles in initiation, promotion and progression in the multistage carcinogenesis model.  Excessive 
generation of ROS breaks balance between ROS and antioxidants in cells leads to oxidative 
stress, which have been proved to associate with CIN, resulting LOH and carcinogenesis. To 
maintain the rapid turnover of intestine epithelium, epithelium cells have high metabolic rate, 
which may produces ROS byproducts and potentially increase oxidative damage of lipids, 
proteins, carbohydrates and nucleid acids. Previous data have indicated that proliferating cells in 
the lower crypt are sensitive towards hydrogen peroxide damage than the upper differentiated 
cells in colon.  The self-renewal and differentiation of ISCs and transient amplification cells 
require redox environment to prevent DNA damage elicited by chronic oxidative stress. 
Organoids generated in our study represent the lower section of crypts covering stem cell zone, 
transient amplification zone, and progenitors for differentiated cells and could be used as 
toxicological model to screen for agents that promote or prevent LOH induced by ROS. 
The IOs generated from our two-step protocol contain fast-cycling Lgr5-expressing stem 
cells and slow-cycling Tert-expressing stem cells, as well as transit-amplifying cells. In fact, these 
cells are highly represented in the organoids generated under our procedures. It is likely that the 
stem cells are the primary targets of carcinogens, since mutations in these cell populations could 
be propagated through multiple cell generations, during which time additional genetic mutations 
could be incurred that ultimately lead to cancer development. However, almost nothing is known 
about the ability of the different stem cell populations to respond to DNA damaging agents and to 
repair their DNA. Endogenous and exogenous agents trigger DNA damage through the chemical 
events including hydrolysis, exposure to reactive oxygen substances, and other reactive 
metabolites 144. Carcinogens dimethylhydrazine (DMH) and azoxymethane (AOM) are alkylating 
agents, which are known to produce DNA adducts, such as O6-methylguanine (O6-MeG) and N7-
methylguanine, and an abnormal methylation pattern145,146.  During DNA replication, 
methyldiazonium ion alkylates DNA bases with formation of DNA adduct O6-MeG to induce G-
to-A transitions to promote colorectal cancinogenesis147. In the colonic crypt, DNA damage 
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induced by AOM is greater in proliferating cells than in the mature cells and apoptosis is also 
primarily targeted to the cells in base of the crypt 147.  
 Variety of DNA-damaging agents including ionizing radiation, UV and natural or man-made 
genotoxic chemicals (eg. methylmethane sulfonate) can be used to induce DNA damages in 
organoids. Tert-positive and Lgr5-positive cells could be then sorted by fluorescence-activated 
cell sorting after the treatment. Relative number of Lgr5 positive and Tert positive cells, and the 
sensitivity of these two distinct groups of ISCs to carcinogens will be evaluated. Information 
about the level of DNA damage, tumour-specific DNA repair responses (eg. ATM activated p53), 
and arrest cell cycle (G1/S, G2/M) in the Lgr5 positive and Tert positive cells may indicate an 
approach to evaluating cancer risk based on the relative number of Lgr5 or Tert cells found in the 
colon. For this reason, improving carcinogen resistance through repair or targeted apoptosis has 
shown promise for colon cancer prevention. 
To establish efficient IOs for colon cancer research in 3D cell culture, first issue to 
address is how to establish a defined long-term culture system. It is important to demonstrate the 
cells in the IOs have biological activity and phenotype as cells in the intact tissue. We have 
produced IOs derived from wild type and ApcMin/+ ESCs using the growth medium containing R-
spondin1, EGF, and Noggin. We characterized the cell composition of these IOs using single cell 
analysis. To make the system more convincing, the architecture of IOs can be determined using 
IHC and IF. Furthermore, to generate IOs with cancer genetic background, the culture system 
may need to be modified; for example, the APC-deficient orgaoinds may prefer different 
conditions with different growth factors and agents, especially medium without Noggin and R-
spondin 1. APC-deficient orgaoinds can be maintained in the defined medium for long time 
period and resemble closely to the epithelium from APC-deficient animals. After the suitable 
culture conditions are determined, the ApcMin/+ organoids can be injected into nude mice to 
confirm the formation of intestinal cancer-like adenomas or tumors. This will prove the function 
of the IOs with genetic deficient. Further attempt to establish the IOs surrogates can be carried by 
 67 
 
gene knockouts and knock-ins with normal or ApcMin/+ ESC-derived organoids. This approach can 
generate more IOs models in vitro for intestine disorder researches. 
 
Although only a few potential applications of intestinal organoids for studying colon 
cancer development are discussed, other applications can also be envisioned. The contribution of 
the work described in this thesis is the development and in-depth thorough characterization of the 
mouse IO system. Genetically-define mouse IOs are anticipated to provide researchers with an 
efficient and well-defined system that can be used in conjunction with mouse models, human IOs 
and other traditional systems to improve our understanding, treatment and prevention of diseases 
of the intestine and colon.     
 68 
 
Table 3: Establish IOs for colon cancer research. 
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APPENDIX I 
ENANTIOCONVERGENT PRODUCTION OF (R)-1-PHENYL-1,2-ETHANEDIOL 
FROM STYRENE OXIDE BY COMBINING THE Solanum tuberosum AND AN 
EVOLVED Agrobacterium radiobacter AD1 EPOXIDE HYDROLASES 
 
Abstract 
Soluble epoxide hydrolase (EH) from the potato Solanum tuberosum and an evolved EH of the 
bacterium 
Agrobacterium radiobacter AD1, EchA-I219F, were purified for the enantioconvergent 
hydrolysis of racemic styrene oxide into the single product (R)-1-phenyl-1,2-ethanediol, which is 
an important intermediate for pharmaceuticals. EchA-I219F has enhanced enantioselectivity 
(enantiomeric ratio of 91 based on products) for converting (R)-styrene oxide to (R)-1-phenyl-
1,2-ethanediol (2.0 ± 0.2 mmol/min/mg), and the potato EH converts (S)-styrene oxide primarily 
to the same enantiomer, (R)-1-phenyl-1,2-ethanediol (221 mmol/min/mg), with an enantiomeric 
ratio of 40 ± 17 (based on substrates). By mixing these two purified enzymes, inexpensive 
racemic styrene oxide (5 mM) was converted at 100% yield to 98% enantiomeric excess (R)-1-
phenyl-1,2-ethanediol at 4.7 ± 0.7 mmol/min/mg. Hence, at least 99% of substrate is converted 
into a single stereospecific product at a rapid rate.   
Keywords: epoxide hydrolase; styrene oxide; phenyl-1,2-ethanediol; enantioconvergent 
INTRODUCTION 
Interest in using epoxide hydrolases (EHs, EC 3.3.2.3), enzymes that hydrolyze epoxides 
to diols for synthesis of enantio-pure compounds (Manoj et al., 2001), is increasing for the 
production of pharmaceuticals (Monterde et al., 2004; Schoemaker et al., 2003). For example, the 
pharmaceutical intermediate, enantio-pure (R)- or (S)-mandelic acid, is used in the synthesis of b-
lactam antibiotics and analytical reagents (Groger, 2001), and (R)-mandelic acid may be made 
from (R)-1-phenyl-1,2-ethanediol (Drummond et al., 1990; Lindstad et al., 1998). EchA is an EH 
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(294 aa) (Rui et al., 2004) from the gramnegative strain Agrobacterium radiobacter AD1 that 
allows the cell to utilize epichlorohydrin as a sole carbon source (Jacobs et al., 1991). A variant of 
EchA was generated by saturation mutagenesis with one amino acid change I219F (EchA-I219F) 
(Rui et al., 2004) that hydrolyzes racemic styrene oxide twofold faster than wild-type EchA while 
having enhanced enantioselectivity for producing (R)-1-phenyl-1,2-ethanediol (enantiomeric ratio 
of 91 vs. 17 based on product) (Rui et al., 2005). Plant soluble EHs play a central role in 
producing cutin, aromatics, and anti-fungal compounds (Morisseau et al., 2000); they have been 
isolated from at least eight plants to date (Elfstrom andWidersten, 2005; Morisseau et al., 2000). 
cDNA encoding a soluble EH (322 aa) from potato (S. tuberosum, StEH) was cloned and 
characterized (Morisseau et al., 2000; Stapleton et al., 1994). The hydrolysis of racemic styrene 
oxide with StEH has been investigated and demonstrated to be an enantioconvergent process with 
initial attack on the a (benzylic) carbon atom of (S)-styrene oxide to form (R)-1-phenyl-1,2-
ethanediol followed by hydrolysis of the b (terminal carbon) atom of (R)-styrene oxide to form 
again (R)-1-phenyl-1,2-ethanediol (Fig. 1B) (Monterde et al., 2004). Therefore, this single 
enzyme was used to form (R)- 1-phenyl-1,2-ethanediol from racemic styrene oxide at 86% 
enantiomeric excess at 100% conversion (Monterde et al., 
2004) although the rate is 300-fold slower for the (R)-styrene oxide reaction. A mixture of EHs 
from the fungi Aspergillus niger and Beauveria sulfurescens have also been used for the 
enantioconvergent synthesis of (R)-1-phenyl-1,2-ethanediol from racemic styrene oxide (Archelas 
and Furstoss, 1998). Here, we report the conversion of racemic styrene oxide to pure (R)-1-
phenyl-1,2-ethanediol using a mixture of StEH, which produces (R)-1-phenyl-1,2-ethanediol from 
both (R)-and (S)-styrene oxide, and EchA-I219F, which converts (R)-styrene oxide to (R)-1-
phenyl-1,2-ethanediol rapidly with slow conversion of (S)-styrene oxide to (S)-diol (Rui et al., 
2005) (Fig. 1). This is the first report of combining an EH from plant and bacterial sources for 
enhancing the enantioselectivity toward a racemic compound with the result: a more rapid 
enzyme system with both higher enantiomeric excess and yield of (R)-phenyl-1,2-ethanediol was 
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created. 
MATERIALS AND METHODS 
Chemicals, Organisms, and Cultivation 
Racemic styrene oxide, (R)-styrene oxide, and (S)-styrene oxide were purchased from 
Sigma Chemical Co. (St. Louis, MO); all the other chemicals were obtained from Fisher 
Scientific Company (Pittsburgh, PA). Escherichia coli strain TG1 (Sambrook et al., 1989) was 
used as the host for cloning and functional expression of genes from the pBS(Kan) plasmids. E. 
coli strain BL21(DE3)plysS and BL21-CodonPlus(DE3)-RIPL strain (Stratagene, La Jolla, CA) 
were utilized as the hosts for expression and purification of the His-tag fusion proteins. All the 
strains were routinely cultivated at 37°C in Luria–Bertani (LB) broth (Sambrook et al., 1989) 
supplemented with appropriate antibiotics (Table 1). All experiments performed (unless otherwise 
stated) by whole cells or sonicated cells were started from single colonies, induced with 1 mM 
isopropyl b-D-thiogalactopyranoside (IPTG) at an optical density at 600 nm (OD600) of 0.2–0.3, 
and harvested after 2 h of IPTG induction at an OD600 of 1.5–2.0. 
General Molecular Techniques 
Enzymes were purchased from New England Biolabs (Ipswich, MA). Polymerase chain 
reaction (PCR) products were purified by Wizard PCR Preps, plasmid DNA was isolated using a 
Midi or Mini Kit (Qiagen, Inc., Chatsworth, CA), and DNA fragments were isolated from agarose 
gels by using a QIAquick Gel Extraction Kit (Qiagen, Inc.). E. coli was electroporated using a 
Gene Pulser/Pulse Controller (Bio-Rad Laboratories, Hercules, CA) at 15 kV/cm, 25 µF, and 
200Ω. Adye terminator cycle sequencing protocol based on the dideoxy method of sequencing 
DNA (Sanger et al., 1977) was used. 
Cloning EH in E. coli 
To stably and constitutively express the potato enzyme StEH in E. coli, an expression 
cassette with a typical E. coli ribosome-binding site (AGGAGG) and an intervening region that 
was used to express nitrilase in E. coli were used here (Kobayashi et al., 1992); this region was 
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introduced by amplifying the gene encoding StEH from pEH10.1 (Stapleton et al., 1994) using 
primers StEH10.1 forward 2 with StEH10.1 reverse (Table 2) (note pEH10.1 lacks a procaryotic 
promoter). Following an initial denaturation at 96°C for 2 min, a thermal amplification profile of 
30 cycles with denaturation at 94°C for 45 s, annealing at 52°C for 45 s, and extension at 72°C 
for 1.5 min, and then a final extension at 72°C for 7 min was used. The PCR product was double 
digested with SalI and BamHI and ligated into plasmid pBS(Kan) to form pBS(Kan)-StEH (Fig. 
2A). 
To purify both EchA-I219F and StEH using a histidine tag, genes encoding both EHs 
were amplified from the pBS(Kan) vectors by PCR using primers STEH PET forward and STEH 
PET reverse for StEH, and EHAD1 PET Front and EHAD1 PET Rear for EchA-I219F (Table 2) 
under the same thermal amplification profile as above. The PCR products were double digested 
by NdeI and HindIII, and inserted into pET28b(þ) (Novagen, Madison, WI) to generate the 
pETStEH and pET-EchA-I219F (Fig. 2B and C) which yielded a six amino-acid His-tag as well 
as a thrombin cleavage sites at the N-terminus of the EHs. Both of genes were sequenced 
completely using primers SEQ PET forward, SEQ PET reverse, EH AD1 108 Rear, and SEQ PET 
Front upstream (Table 2) to confirm there was no amino acid change in the recombinant plasmids 
and to confirm the presence of the I219F mutation in EchA-I219F. 
To overexpress the EchA-I219F, pET-EchA-I219F was transformed into 
BL21(DE3)plysS by electroporation. For pET-StEH, BL21-CodonPlus(DE3)-RIPL carrying 
genes encoding extra copies of argU, ileY, leuW and proL rare codon tRNAwas used since 5 out 
of 10 arginines in the StEH gene are encoded by the rare codons AGA or AGG (Stratagene). 
Protein Purification 
Both EchA-I219F and StEH with a His-tag were purified by Ni-NTA column (Invitrogen, 
Carlsbad, CA). An overnight culture of BL21(DE3)plysS harboring pET-EchA-I219F was 
exponentially grown in 25 mL LB medium with kanamycin (50 µg/mL) and chloramphenicol (34 
µg/mL), then diluted 1:100 in 1 L of fresh LB medium with the same antibiotics, and incubated at 
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378C. IPTG (1 mM) was added at cell OD600 about 0.3, and the culture was incubated at 37°C 
overnight. One-liter cells were harvested by centrifugation at 10,000g, 4°C for 10 min and 
resuspended in 10 mL of the native purification buffer (50 mM NaH2PO4, pH 8.0, 0.5 M NaCl). 
Bacteria lysis was performed by passing the cell resuspension (10 mL) through a French Pressure 
Cell Press (Spectronic Instruments, Rochester, NY) and centrifuged at 20,000g, 4°Cfor 1 h to 
pellet the cell debris. The supernatants containing the soluble EHs were loaded into a 10-mL Ni-
NTA column for purification. His-tagged enzymes were eluted with native purification buffer 
with imidazole (250 mM) and dialyzed against TE buffer (100 mM Tris-Cl, 0.2 mM EDTA) 
overnight and then dialyzed against storage buffer (10 mM Tris-SO4, 1 mM EDTA, 1 mM 
bmercaptoethanol, 0.02% sodium azide, and 20 % glycerol, pH 7.5). Purification of StEH was 
performed as above except BL21-CodonPlus (DE3)-RIPL harboring pET-StEH was cultured in 
LB with kanamycin (50 µg/mL), chloramphenicol (34 µg/mL), and streptomycin (50 µg/mL) for 
maintaining of the pET-StEH, the pACYC-based plasmid with extra copies of the argU and proL 
tRNA genes, and the pSC101-based plasmid carrying extra copies of the argU, ileY, and leuW 
tRNA genes, respectively (Stratagene). The concentrations of the purified enzymes were 
evaluated by comparing standard protein samples (Precision plus protein standards, Bio-Rad 
Laboratories) of known concentration on polyacrylamide gel electrophoresis in sodium dodecyl 
sulfate (SDS–PAGE). To corroborate these values, a method based on spectrophotometric 
measurement of the purified enzymes in 6 M guanidine at 280 nm was used (Edelhoch, 1967; Gill 
and Hippel, 1989). Both of the methods gave similar results for the concentration of 
His-EchA-I219F (1 mg/mL) and His-StEH (1 mg/mL), which was used for the calculation for the 
specific activity of enzymes. 
Enzyme Assays 
To test initial StEH expression in E. coli harboring pBS(Kan)-StEH, a spectrophotometric 
method was used (Rui et al., 2005) with whole cells. Briefly, 2 mL of exponentially growing 
whole cells were incubated with 5 mM racemic styrene oxide in 15 mL glass vial at 37°C for 1 h 
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with shaking at 250 rpm, and then the vial was incubated at 50°Cfor 50 min after adding 1 mL of 
100mM 4-(4-nitrobenzyl)-pyridine. To detect the remaining racemic styrene oxide, 1 mL of 50% 
triethylamine was added to the vial (in acetone), and the absorbance of mixture was measured at 
OD600. 
To make the crude extract for the enzyme assays, exponentially growing cells harboring 
EHs were harvested and adjusted to OD600 to 1 in TEM buffer (10 mM Tris- HCl, 1mM EDTA, 
and 1 mM mercaptoethanol, pH 7.4), and the cells were sonicated 10 times for 10 s at 10 W (with 
a 1-min interval on ice between two sonications) with a F60 sonic dismembrator (Fisher 
Scientific, Pittsburgh, PA). The concentration of EH in the sonicated cells was estimated from 
SDS–PAGE (for specific rates). 
For the reactions with single purified enzymes, the hydrolysis of racemic styrene oxide, 
(S)-styrene oxide, or (R)-styrene oxide was performed with 60–300 µg His-StEH and 160–320 µg 
His-EchA-I219F. The enzymes were mixed in 4–10 mL TEM buffer and contacted with 5 mM of 
these substrates at 37°Cwith shaking (250 rpm) for 40–60min. For the hydrolysis of racemic 
styrene oxide by the mixture of EHs, His-StEH (40 µg), and His-EchA-I219F (200 µg) were 
mixed in 5mLTEMbuffer and incubated with 5mMracemic styrene oxide. To investigate the 
inhibition of (R)-styrene oxide hydrolysis by (R)-1-phenyl-1,2-ethanediol with StEH, (R)-1-
phenyl-1,2-ethanediol (2.5 mM) and 2.5 mM (R)-styrene oxide were incubated together with 
purified His-StEH (80 µg) in 5mLreaction at 37°C with shaking (250 rpm) for 1h. For the control, 
2.5mM (R)-styrene oxide was added to the same amount of purified His-StEH (no (R)-1-phenyl-
1,2-ethanediol). The initial rates of the enzymes toward the different substrates were calculated. 
Identification of Products from Hydrolysis of Styrene Oxide 
 The reaction products were analyzed by chiral highperformance liquid chromatography 
(HPLC) for the production of enantiomer of diols (Rui et al., 2005). Briefly, samples (500 µL) 
were withdrawn by syringe from the reaction and quenched by extracting with 800 µL ethyl ether. 
HPLC (Waters Corp., Milford, MA) including 515 HPLC pumps, a 996 photodiode array 
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detector, and Millenium32 Chromatography Manager Software was used to determine the 
absolute configuration of the enantiomers of 1-phenyl-1,2-ethanediol formed from hydrolyzing 
styrene oxide. The (R)- and (S)-1-phenyl-1,2-ethanediol were separated by a Chiralcel OB (4.6 X 
250 mm) column (Chiral Technologies, Inc., Exton, PA) using hexane/2-propanol (76/24, v/v) as 
the eluent with a flow rate of 0.5 mL/min with retention times of 10.2 min and 11.2 min, 
respectively. To quantify (R)- and (S)-1-phenyl-1,2-ethanediol formation and styrene oxide 
remaining in the reaction, UV-visible spectra were acquired using a diode array detector 
(scanning from 200 to 600 nm). The HPLC detection limit under these conditions for racemic 
styrene oxide was measured using serial dilutions of racemic styrene oxide from 5 to 0.01 mM in 
TEM buffer and extraction with ethyl ether. 
The enantiomeric ratio was calculated based on substrate disappearance as determined by 
gas chromatography (GC). Samples were prepared by withdrawing 500 µL liquid from the 
reaction and extracting the styrene oxide with the same volume methlyethene chloride with 5m 
Mmesitylene. A gas chromatograph (Agilent 6890 series) equipped with a 30 m X 0.25 mm 
Chiraldex G-TA capillary column (Astec,Whippany, NJ) and a flame-ionization detector (FID) 
was used. Hydrogen (40 mL/min) and air (400 mL/min) were supplied to the FID, and the carrier 
gaswas nitrogen (0.7mL/min). Samples injected into the GC were analyzed isothermally at 
225°C, and the retention times of (S)-styrene oxide and (R)-styrene oxidewere 8.16 min and 9.75 
min, respectively. Concentrations were calculated by comparing the peak area with the peak area 
formed by the internal standard mesitylene (5 mM). The enantioselectivity 
(E) (Chen et al., 1982) = ln [(1 - C)(1 - EES)]/ln [(1 - C)(1  + EES)], where conversion (C) = 1 - 
[styrene oxide]/[initial styrene oxide] and EES is the enantiomeric excess based on substrates = 
([S-styrene oxide]-[R-styrene oxide])/([S-styrene oxide]+[R-styrene oxide]) for EchAI219F and 
([R-styrene oxide]-[S-styrene oxide])/([R-styrene oxide] + [S-styrene oxide]) for StEH. The 
enantiomeric ratio of each enzyme was calculated when roughly 50% of the racemic styrene 
oxide was converted (C = 0.5). EEP is the enantiomeric excess based on the products = ([R-diol] - 
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[S-diol])/ ([R-diol] + [S-diol]). 
RESULTS 
Expression of StEH in E. coli 
To express StEH in a procaryotic system, pBS(Kan)-StEH was constructed by cloning the 
gene for StEH  into pBS(Kan) along with a suitable ribosome-binding site (Kobayashi et al., 
1992) and transformed into E. coli strain TG1 under the control of a constitutive lac promoter 
(Fig. 2A). StEH with activity toward styrene oxide was obtained (162 nmol/min/mg protein for 
racemic styrene oxide using whole cells). To purify both of StEH and EchA-I219F, the EH genes 
were cloned into pET28b(+) by fusing the EH genes 
between the NdeI and HindIII site, so that the genes were under the control of T7 promoter and a 
six amino acid His-tag and thrombin site were added at the N-terminus (Fig. 2B and C). 
Protein Purification 
Both EHs with the His-tag at the N-terminus were purified using a Ni-NTA matrix; the 
purity was checked using SDS–PAGE (Fig. 3) and the enzymes were both found to be greater 
than 90% pure. Bands with approximately 37 kDa molecular weight were observed 
corresponding to both His-EchA-I219F and His-StEH (predicted sizes of 36.3 kDa and 38.5 kDa, 
respectively). 
Conversion of Racemic Styrene Oxide by StEH and EchA-I219F 
The detection limit was determined by HPLC to be 99% for racemic styrene oxide. 
Purified His-StEH demonstrated a rapid rate as racemic styrene oxide was converted to (R)-1-
phenyl-1,2-ethanediol at an initial rate of 22 ± 1 mmol/min/mg with the corresponding 
disappearance of (S)-styrene oxide; the rate of (S)-1-phenyl-1,2-ethanediol formation was 300-
fold lower (Table 3). Due to the 10-fold slower rate of 
StEH on (R)-styrene oxide, the reaction can be made to go to completion, but it took 15 h to 
convert 96 ± 4% racemic styrene oxide to diols with product enantiomeric excess of 87±4% in 
favor of (R)-1-phenyl-1,2-ethanediol which agrees with the earlier report (100% conversion with 
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86% enantiomeric excess) (Fig. 4A) (Monterde et al., 2004). Similar results were obtained here 
by contacting crude extracts of His-StEH with racemic styrene oxide: at least 99% conversion of 
substrates with 85.4 ± 0.4% enantiomeric excess.  
Purified EchA-I219F was found to convert racemic styrene oxide to (R)-1-phenyl-1,2-
ethanediol 11 times faster than to (S)-1-phenyl-1,2-ethanediol with high rates (Table 3). Although 
EchA-I219F that lacks a His-tag is more active than the wild-type enzyme (Rui et al., 2005), 
purified recombinant His-EchA-I219F showed lower activity toward racemic styrene oxide 
(2.0±0.2 µmol/min/mg) (Table 3) compared with the wild-type EchA that lacks a His-tag (5.2 
µmol/min/mg) (Rui et al., 2005). The same discrepancy was seen with the crude extracts, which 
indicates the His-tag at the N-terminus decreases the rate of reaction but did not affect 
enantioselectivity (Fig. 4B). 
The conversion of racemic styrene oxide by purified His-StEH and His-EchA-I219F were 
also monitored by GC analysis based on the disappearance of each enantiomer of racemic styrene 
oxide. The enantiomeric ratio of racemic styrene oxide hydrolysis by purified His-StEH was 40 ± 
17 (Table 3), and the rate of production of (R)-1-phenyl-1,2-ethanediol from (S)-styrene oxide 
hydrolysis was 17.2 ± 0.4 µmol/min/mg. This shows the preference for (S)-enantiomer 
disappearance for StEH, while the His-EchA-I219F, which catalyzed primarily the hydrolysis of 
the (R)-enantiomer, had an enantiomeric ratio of 10.0 ± 0.9, with the rate of (R)-1-phenyl-1,2-
ethanediol formation as 1.9 ± 0.1 µmol/min/mg, but only 0.17 ± 0.03 µmol/min/mg for (S)-1-
phenyl-1,2-ethanediol formation (Table 3).  
Enantioconvergent Production of (R)-1-Phenyl-1,2-ethanediol  
Since the His-StEH and His-EchA-I219F enzymes can hydrolyze (S)-styrene oxide and 
(R)-styrene oxide, respectively, to (R)-phenyl-1,2-ethanediol at high rates as well as high 
enantioselectivity, a mixture of purified His-StEH and His-EchA-I219F was used for hydrolyzing 
racemic styrene oxide. The ratio of the purified His-StEH and His-EchAI219F to be used in the 
reaction system was based on the rate of pure styrene oxide hydrolysis by each enzyme, and the 
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enantiomeric ratio based on substrate disappearance. To determine the rates with purified 
substrates, purified His-EchA-I219F or His- StEH was contacted with 5mM pure (S)-styrene 
oxide and (R)-styrene oxide (note rates shown in Table 3 are with racemic mixtures). The rate of 
(R)-phenyl- 1,2-ethanediol formation from (S)-styrene oxide by purified His-StEH was 18 ± 1 
µmol/min/mg, while the rate of (R)-phenyl-1,2-ethanediol formation from (R)-styrene oxide by 
His-StEH was only 1.27 ± 0.05 µmol/min/mg. For purified His-EchA-I219F, the (R)-phenyl-1,2-
ethanediol formation rate was 2.3 ± 0.1 µmol/min/mg which is 10-fold faster than the (S)-phenyl-
1,2-ethanediol formation from pure (S)-styrene oxide hydrolysis by this enzyme. Using the rates 
of (R)-phenyl-1,2-ethanediol formation by the two enzymes as well as the ratio of enantiomeric 
ratio (40 ± 17 vs. 10.0 ± 0.9) as a guide, the amounts of His-StEH and His-EchA-I219F enzyme 
for the enantioconvergent production of (R)-1-phenyl-1,2-ethanediol from racemic styrene oxide 
were 40 µg His-StEH and 200 µg His-EchAI219F. Racemic styrene oxide (5 mM) was 
hydrolyzed by purified His-StEH and His-EchA-I219F to pure (R)-1-phenyl-1,2-ethanediol in 1 h 
with 99.9 ± 0.1% conversion and an enantiomeric excess of the product (R)-1-phenyl-1,2-
ethanediol of 97.9 ± 0.2% (Fig. 4C). The initial rate of racemic styrene oxide hydrolysis was 4.7 
± 0.3 µmol/min/mg, which was corroborated by the production of (R)-1-phenyl-1,2-ethanediol at 
4.7 ± 0.7 µmol/min/mg (Table 3). The enantiomeric ratio of the EH mixture toward racemic 
styrene oxide (calculated by monitoring substrate disappearance) was only 2.2 ± 0.3, as expected, 
since each purified enzyme, His-EchA-I219F and His-StEH, reacted primarily with (R)- or (S)-
styrene oxide, at the same time (Fig. 4D) (werecognize this ratio has little meaning for a dual 
enzyme system). 
Stability of Styrene Oxide 
TEM buffer and sonicated E coli TG1 or BL21-Codon-Plus(DE3)-RIPL (no enzyme) 
were contacted with racemic styrene oxide (5 mM) to determine if styrene oxide decomposition 
impacts the rate of racemic styrene oxide hydrolysis by the EHs. Only 4.4% of racemic styrene 
oxide decomposed in TEM system after 45 min, and 10% decomposition occurred for both TG1 
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and BL21-Codon-Plus(DE3)-RIPL after 2 h of incubation. Because all the experiments performed 
by purified enzymes were reacted with substrates in the TEM system for less than 1 h and the 
experiments performed by sonicated cells were completed within 2 h, the decomposition of 
substrate had little impact on the reaction rates. 
Inhibition of (R)-Styrene Oxide Hydrolysis by (R)-1-Phenyl-1,2-ethanediol With StEH 
To investigate if (R)-styrene oxide hydrolysis was inhibited by the (R)-1-phenyl-1,2-
ethanediol formed from racemic styrene oxide degradation with His-StEH, 2.5 mM (R)-1-phenyl-
1,2-ethanediol and 2.5 mM (R)-styrene oxide were incubated together with purified His-StEH. 
The initial rate of (R)-1-phenyl-1,2-ethanediol production from (R)-styrene oxide was similar 
with the control at the beginning; however, the rate decreased by 36% after 15 min. Hence, (R)-
styrene oxide hydrolysis by StEH is inhibited by the product (R)-1-phenyl-1,2-ethanediol; this 
causes the single potato enzyme to require large reaction times to completely convert racemic 
styrene oxide to (R)-1-phenyl-1,2-ethanediol (Fig. 4A) which is the motivation for using two 
enzymes. 
DISCUSSION 
We show clearly in this work that the mixture of EHs from a bacterial source (EchA-
I219F) and a plant source (StEH) produce (R)-1-phenyl-1,2-ethanediol rapidly (in 1 h) with both 
high yield (99.9 ± 0.1%) and high enantiomeric excess of (R)-1-phenyl-1,2-ethanediol (97.9 ± 
0.2%). This process is an improvement over previous systems which utilize StEH alone but 
produce only 86% enantiomeric excess (R)-1-phenyl-1,2-ethanediol while requiring 15h 
conversion time due to the slow rate of this enzyme for (R)-styrene oxide and the inhibition of 
(R)-1-phenyl-1,2-ethanediol (Fig. 4A) (Monterde et al., 2004). The EchA-I219F/StEH mixture is 
also better than the two fungal EH system, which produces only 89% enantiomeric excess and 
requires 2h conversion time (Archelas and Furstoss, 1998). 
The EchA-I219F was obtained from our previous work via active site engineering of the 
wild-type EchA by introducing the phenylalanine residue into position I219, which has van der 
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Waals contact with both F108 and Y215. The substitution of phenylalanine for isoleucine shifts 
the position of (R)-styrene oxide to favor the enantioselectivity toward formation of (R)-1-phenyl-
1,2-ethanediol (Rui et al., 2005). This enzyme is not suitable by itself for enantiomeric conversion 
since it converts (S)-isomer of the racemic substrate into (S)-1-phenyl-1,2-ethanediol of the 
racemic styrene oxide after consumption of (R)-isomer. EchA-I219F also does not completely 
convert racemic styrene oxide (50% yield, Fig. 4B) because the conversion of the (S)-isomer of 
the racemic substrate is inhibited by the (S)-diol that is formed (Rui et al., 2005). Hence, by using 
two enzymes, we overcame the problems of each and converted racemic styrene oxide rapidly to 
nearly pure (R)-1-phenyl-1,2- ethanediol (98% enantiomeric excess and 99% conversion). 
This prevents the loss of 50% of the substrate and allows an inexpensive substrate to be 
used. There is no chemical equivalent process known to date. 
 
The authors are grateful for the gift of pEH10.1 by Dr. Belknap (United States Department of 
Agriculture). 
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Figure 1. Schematic of enantioselective hydrolysis of racemic styrene oxide by: (A) EchA-I219F 
to form (R)-1-phenyl-1,2-ethanediol and (S)-1-phenyl-1,2-ethanediol, (B) StEH to form (R)-1-
phenyl-1,2-thanediol and a small amount of (S)-1-phenyl-1,2-ethanediol, and (C) a mixture of 
EchA-I219F and StEH toform (R)- 1-phenyl-1,2-ethanediol only. 
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Figure 2. Schematics of plasmids (A) pBS(Kan)-StEH, (B) pET-StEH, and (C) pET-EchA-I219F. 
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Figure 3. SDS–PAGE to check the purification of His-I219F and His-StEH. E, crude extract; F, 
flow through; and P, purified enzyme. 
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Figure 4. Enantioselective hydrolysis of 5mM racemic styrene oxide by purified enzymes. 
Production of (R)-1-phenyl-1,2-ethanediol from racemic styrene epoxide by: (A) purified His-
StEH (160 µg in a 10mL reaction), (B) purified His-EchA-I219F (200 µg in a 5mL reaction), (C) 
a mixture of purified His-StEH and His-EchA-I219F (40 µg and 200 µg, respectively in a 5 mL 
reaction), and (D) disappearance of racemic styrene oxide by the mixture of enzymes (40 µg and 
200 µg, respectively in a 5 mL reaction). One of two duplicate experiments shown. 
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Table 1. Strains and plasmids used in this article. 
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Table 2. Primers used in this work with restriction enzymes underlined and the modified 
ribosome-binding site in lowercase. 
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Table 3. Specific activity of His-StEH and His-EchA-I219F toward 5 mM racemic styrene 
oxide. 
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APPENDIX II 
AN INSECT FARNESYL PHOSPHATASE HOMOLOGOUS TO THE N-TERMINAL 
DOMAIN OF SOLUBLE EPOXIDE HYDROLASE 
Abstract 
In insects, farnesyl pyrophosphate (FPP) is converted to juvenile hormone (JH) via a 
conserved pathway consisting of isoprenoid derived metabolites. The first step of this pathway is 
presumed to be hydrolysis of FPP to farnesol in the ring gland. Based on alignment of putative 
phosphatases from D. melanogaster with the phosphatase domain of soluble epoxide hydrolase, 
Phos2680 and Phos15739 with conserved phosphatase motifs were identified, cloned and 
purified. Both D. melanogaster phosphatases hydrolyzed para-nitrophenyl phosphate, however, 
Phos15739 also hydrolyzed FPP with a Kcat/Km of 2.1 X 105 M−1s−1. RT-PCR analysis revealed 
that Phos15739 was expressed in the ring gland and its expression was correlated with JHIII titer 
during development of D. melanogaster. N-acetyl-S-geranylgeranyl-L-cysteine was found to be a 
potent inhibitor of Phos15739 with an IC50 value of 4.4 μM. Thus, our data identify Phos15739 as 
a FPP phosphatase that likely catalyzes the hydrolysis of FPP to farnesol in D. melanogaster. 
INTRODUCTION 
Juvenile hormones (JHs), the unique sesquiterprenoid hormones synthesized and secreted 
by the corpora allata (CA) region of ring glands play important roles in insect embryonic 
development, metamorphosis, and reproduction [1, 2]. JH is critical for insect maturation and the 
concentration of JH is regulated by tissue specific rates of biosynthesis, release, and degradation 
[3]. Because FPP hydrolysis to farnesol is generally considered to be the first committed step in 
JH biosynthesis [2], this step may be critical in controlling endogenous JH levels and/or rates of 
JH production. Insects synthesize FPP, the 15-carbon precursor of JH, dolichol, ubiquinon and 
prenylated proteins, from acetyl-CoA via the classical mevalonate pathway. Thus, insect enzymes 
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involved in FPP synthesis have been identified based on conservation of the mevalonate pathway 
between vertebrates and insects. However, due to the apparent lack of vertebrate orthologs of 
enzymes involved in the synthesis of JH from FPP, no structural data for the insect FPP 
pyrophosphatase, farnesol oxidase or farnesal dehydrogenase are available [2, 5]. JH acid 
methyltransferase and JH epoxidase, the last two enzymes involved in JH biosynthesis, have been 
previously identified [4, 6]. 
Recently, the N-terminal phosphatase domain of mammalian soluble epoxide hydrolase 
was reported to be in the haloacid dehalogenase superfamily [7]. Structure and sequence 
alignment of mammalian sEH with phosphonoacetaldehyde hydrolase (PhAH) from Bacillus 
cereus, haloacid dehalogenase (HAD) from Xanthobacter autotrophicus, and phosphoserine 
phosphatase (PSP) from Methanococcus jannaschii revealed three common motifs with Asp-9 as 
the catalytic nucleophile [7]. Previously, the effect of hsEH on isoprenoid phosphate hydrolysis 
was evaluated in our lab. FPP was found to be a substrate of the N-terminal domain of hsEH with 
a turnover number of 0.25 ± 0.07 s−1, and a series of isoprenoid-derived compounds were 
identified as hsEH phosphatase inhibitors [8]. Based on the hypothesis that mammalian soluble 
epoxide hydrolases evolved by fusion of the primitive haloacid dehydrogenase N-terminal 
domain and the primitive haloalkane dehalogenase C-terminal domain [9], we reasoned that a 
distinct and separate N-terminal phosphatase domain might exist in insects. Furthermore, due to 
the uniqueness of JH biosynthesis in insects, inhibitors disrupting FPP hydrolysis to farnesol 
might be of potential use as insect growth regulators. 
Here, we report the identification of phosphatase candidates from the D. melanogaster 
genome by comparing conserved regions of phosphatases from hsEH, PhAH, HAD and PSP. 
Based on analysis of substrate specificity, localization and developmental expression, our data 
suggest that Phos15739 catalyzes the hydrolysis of FPP to farnesol in D. melanogaster. 
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MATERIALS AND METHODS 
Chemicals and heterologous expression 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO) unless 
otherwise stated. Geranylgeranyl pyrophosphate was purchased from Biomol International 
(Plymouth Meeting, PA). Plasmids pFLC-1 containing the cDNA of D. melanogaster CG2680 
and CG15739 were obtained from the Drosophila Genomics Resource Center. The Bac-to-Bac 
Baculovirus Expression System (Invitrogen, Carlsbad, CA) was used for expressing recombinant 
proteins. Sf21 insect cells were grown at 27°C in EX-CELL™420 insect serum-free medium (JRH 
Biosecience, Levexa, KS) supplemented with 3% fetal bovine serum (JRH Biosecience, Levexa, 
KS) and penicillin-streptomycin. 
Reverse transcription 
Total RNA from ring glands of early 3rd instar larva was isolated using Trizol (Invitrogen, 
Carlsbad, CA, USA). The concentration and quality of the RNA samples were estimated by 
measuring optical density at 260nm, 260nm/280 nm ratio and agarose gel electrophoresis. After 
isolation, RNA was stored at −80°C until analyzed. RNAs were reverse transcribed with random 
primers and M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Primers used for 
amplifying genes encoding putative phosphatases from D. melanogaster are listed in 
Supplemental Table 1. PCR conditions were 95°C for 2 min followed by 30 cycle of 95°C for 30 
s; 55°C, 30 s, 72°C, 1 min; with a final extension at 72°C for 10 min. 
Construction of baculoviruses expressing Phos2680 and Phos15739 
The cDNAs of CG2680 and CG15739 were subcloned into pFastBac-HTa by PCR 
amplification using primers CG2680-v-forward: 5′-
ACGAACCAACGAATTCATGTCGCCACCACGAC-3′, CG2680-v-reverse: 5′-
CGGCCCGCGGAA GCTTACCTATTTTTGAATATTTTC-3′; CG15739-v-forward: 5′-
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ACCAGAACGGGAATTCATGGC CAAACCCCAGCAC-3′, and CG15739-v-reverse: 5′-
TCCTCCGCCGAAGCTTGTCTAGACACG CGACTTG -3′ respectively. Following an initial 
denaturation at 95°C for 1 min, an amplification profile of 30 cycles with denaturation at 95°C for 
30 sec, annealing at 52°C for 30 sec, and extension at 72°C for 1 min, and then a final extension 
at 72°C for 7 min was used. The PCR products were double digested with EcoR1 and HindIII and 
ligated into plasmid pFactBac-HTa to form pFastBac-2680 and pFastBac-15739. The generation 
of baculoviruses expressing Phos2680 and Phos15739 was performed according to 
manufacturer’s instructions. 
To construct the Phos15739 variant Asp28Ala (D28A), primers DM15739D28A-forward: 
5′-ACCGGGTGGTCAGCGCGATCGATGGGCTTCCTG-3′ and DM15739D28A-reverse: 5′-
ACGCCATCGATCGCGCTGACCACCCGGTCGAAAG-3′ were used for site-direct 
mutagenesis. The same PCR program and method listed above were used. 
Protein purification 
Phos2680, Phos15739 and Phos15739-D28A with N-terminal His tags were purified on 
HIS-Select Cartridges (Sigma-Aldrich; St. Louis, MO) following the manufacturer’s instructions. 
His-tagged proteins were concentrated by Amicon ultra centrifugal filter devices (Millipore; 
Billerica, MA). Protein concentration and purity were determined by BCA assay reagent from 
Pierce (Rockford, IL) and SDS-PAGE respectively. 
Enzyme assays 
The specific activity of Phos2680 and Phos15739 toward p-NPP was measured in 96-well 
plates. Phos2680 (50 ng) or Phos15739 (50 ng) were added in 50 μL reaction buffer (100 mM 
MES, pH 6.0, 2 mM Mg 2+) containing substrate with final concentrations from 0 mM to 20 mM 
at room temperature for various times, followed by adding 100 μL NaOH (0.5N) to stop the 
reaction. The nitrophenol product was detected at OD405 with a SpectraMax-190 plate reader 
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(Molecular Devices, Sunnyvale, CA). 
The analysis of Phos2680 and Phos15739 activity using isoprenoid monophosphate and 
pyrophosphate substrates was determined using PiPer Phosphate Assay Kit (Molecular Probes; 
Eugene, OR) as previously described [8]. Reaction mixtures of isoprenoid mono- or 
pyrophosphate substrates and Phos2680 or Phos15739 were incubated in 100 μL of reaction 
buffer at room temperature for various times, followed by adding 50 μL reagent containing 
EDTA, maltose, maltose phosphorylase, glucose oxidase, horseradish peroxidase, and Amplex® 
Red reagent. The same assay was also used to determine whether Phos15739 was a 
pyrophosphatase or monophosphatase by adding inorganic pyrophosphatase to the reaction 
mixture before reagent mixture. 
Inhibitors of Phos2680 and Phos15739 
Inhibition assays were performed using p-NPP as substrate as described [8] with slight 
modification. N-acetyl-S-geranyl-L-cysteine, N-acetyl-S-farnesyl-L-cysteine, N-acetyl-S-
geranylgeranyl-L-cysteine and S-Farnesyl-thioacetic acid were pre-incubated with Phos2680 (50 
ng) or Phos15739 (150 ng) for 5 min, and then reacted with 640 μM or 240 μM p-NPP in reaction 
buffer (MES, 100 mM, pH 6.0, Mg2+, 2 mM). The reaction was stopped by adding 200 μL of 0.5 
N NaOH and absorbance was measured at 405 nm. 
TLC identification of products from hydrolysis of FPP 
Production of farnesol from FPP by Phos15739 was monitored on TLC using 
hexane/ethyl-acetate (4:1) as the mobile phase [10]. A ten microliter reaction mixture of 1 mM 
FPP and 400 ng Phos15739 was quenched with an equal volume of methanol at 1 min and 30 
min, and loaded on the TLC plate. Pure FPP, FMP, FOH and Phos15739 were utilized as controls. 
Quantitative RT-PCR (Q-RT-PCR) 
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The CG15739 transcript in different development stages of Drosophila was quantified 
using a 7500 Fast Real-time PCR system (Applied Biosystems, Foster City, CA). Total RNAs 
were extracted from different stages of D. melanogaster and RNAs were converted to cDNAs as 
described above. Q-RT-PCR was carried out in 20 μl reaction volume containing SYBR Green 
Master Mix (Applied Biosystems), total RNAs, and the specific primer pairs (Supplemental Table 
1). Cycling conditions were 1 cycle at 95°C for 20 s, followed by 40 cycles of 3 s at 95°C and 30 
s at 60°C. Melting analysis was performed at 60°C to 95°C. Each sample was run 3 or more times 
for Q-RT-PCR analyses. The mRNA expression of CG15739 gene was normalized using actin as 
the endogenous control gene. 
RESULTS 
Homology analysis 
Following release of the D. melanogaster genome sequence, eight gene encoded 
products, Phos2680, Phos5567, Phos10352, Phos11291, Phos15739, Phos17294, Phos32487 and 
Phos32488 were identified as putative phosphatase paralogues. Alignment of these (Fig. 1A) 
showed that they had one or more conserved motifs typical of phosphatases including; 1) an 
aspartic acid residue as the catalytic nucleophile, 2) a serine or threonine for binding the 
phosphate group, and, 3) two aspartic acid residues thought to be important for Mg2+ binding [7, 
11]. Two phosphatases (Phos17294 and Phos10352) were eliminated from further analysis 
because they lacked the second serine or threonine conserved motif. CG2680 and CG15739 
encoded gene products containing a DXDGV motif, the conserved sequence found in the N-
terminal phosphatase domain of hsEH (Fig. 1B), while CG11291 had a less well conserved 
SXDGV motif. Reverse transcription analysis suggested that 6 phosphatase genes were expressed 
in early 3rd instar larva (Fig. 2A), however, only CG2680, CG11291 and CG15739 were 
expressed in ring glands of early 3rd instar larva (Fig. 2B). Based on these results, Phos2680 and 
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Phos15739 were selected as the most likely farnesyl phosphatase candidates. 
Enzyme activity 
p-NPP was initially used as a substrate to measure phosphatase activity of purified 
recombinant Phos2680 and Phos15739. Both Phos2680 and Phos15739 had p-NPPphosphatase 
activity, with Vmax of 36 μmol/min/mg and 6.1 μmol/min/mg, with corresponding Km values of 
640 μM and 240 μM respectively (Supplemental Table 2). Phos2680 and Phos15739 were Mg2+-
dependent and had maximum p–NPP activity at pH 6.0 (data not shown). 
Since the N-terminal domain of hsEH was reported to be a phosphatase with isoprenoid 
mono- and pyrophosphate hydrolysis activity [8], different isoprenoid mono- and pyrophosphates 
were also utilized as substrates for Phos2680 and Phos15739. The kinetics of Phos2680 toward 
most of the isoprenoid mono- and pyrophosphates substrates except IMP could not be determined 
with the concentration ranges used. IMP was a good substrate for Phos2680 with Km of 35 μM 
and Vmax of 59 μmol/min/mg. Unlike Phos2680, Phos15739 catalyzed hydrolysis of most of the 
isoprenoid mono- and pyrophosphates substrates and had a high turnover rate and Vmax. The 20-
carbon substrates GGMP and GGPP, however, were not good substrates (Table 1). GMP was the 
best Phos15739 substrate with Kcat/Km of 18 X 105 M−1 s−1. IMP, FMP and FPP were also good 
substrates with Kcat/Km of 1.2 X 105, 3.1 X 105, 2.1 X 105 M−1 s−1 respectively. IPP and GPP 
were considered to be weak substrates compared with the other mono- and pyrophosphates 
analyzed. 
For all the isoprenoid pyrophosphates substrates used, we found no evidence of 
pyrophosphate release from Phos15739 catalyzed reactions (data not shown). Thus we conclude 
that Phos15739 is a phosphatase rather than a pyrophosphatase. The final product of FPP 
hydrolysis by Phos15739 was confirmed to be farnesol using thin layer chromatography (Fig. 3). 
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To identify the catalytic nucleophile of Phos15739, the Asp-28 of Phos15739 was 
mutated to Ala-28 to generate variant Phos15739D28A. The enzymatic activity of purified 
Phos15739D28A was then measured using p-NPP and FPP as substrates. No activity was detected 
with either substrate under the same reaction conditions as the positive control Phos15739 (data 
not shown). 
Inhibitors of Phos2680 and Phos15739 
Because of similarities of Phos2680 and Phos15739 with the N-terminal domain of hsEH, 
five previously used inhibitors of the N- terminal phosphatase domain of hsEH [8, 12] were 
evaluated with both Phos2680 and Phos15739. S-Farnesyl-thioacetic acid and N-acetyl-S-
geranylgeranyl-L-cysteine were good inhibitors of Phos2680 with IC50 values of 5.1 ± 1.4 and 14 
± 1.9 μM respectively (Table 2). For Phos15739, N-acetyl-S-geranylgeranyl-L-cysteine (IC50 of 
4.4 ± 2.0 μM) was the best inhibitor of the compounds tested (Table 2), followed by N-acetyl-S-
geranyl-L-cysteine and N-acetyl-S-farnesyl-L-cysteine (IC50 = 6.3 ± 1.7 and 28 ± 6.8 μM 
respectively). However, S-Farnesyl-thioacetic acid and taurolithocholic acid 3-sulfate were poor 
inhibitors of Drosophila Phos15739. N-acetyl-S-farnesyl-L-cysteine was previously found to be 
the best inhibitor of hsEH, indicating inhibitor selectively among Phos2680, Phos15739 and 
hsEH. 
Stage-Specific Expression of CG15739 
To analyze the developmental regulation of CG15739 expression, CG15739 transcript 
levels were monitored using Q-RT-PCR. In the developmental stages we evaluated, CG15739 
transcript level changes were correlated with previously published JH titer levels (Fig. 4). Setting 
expression levels of second instar larvae as 1.0, transcript expression levels of 3rd early larvae 
decreased to 0.4, and were barely detectable in 3rd instar wondering larvae and pupae (0.1 for 
both) corresponding to low JH titer. On the other hand, the highest CG15739 transcript levels 
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were detected in adult (male 5.2, female 3.0), at the time of maximal JHIII titer [13]. 
DISCUSSION 
Identifying enzymes involved in the conversion of farnesyl pyrophosphate to JH has been 
difficult due to the apparent lack of this pathway in vertebrates. Recently, an ortholog of the 
Bombyx mori methyltransferase which converts farnesoic acid to methyl farnesonate was 
identified in the Aedes expressed sequence tags (ESTs) collection [4], and a cytochrome P450 
(CYP15A1) catalyzing stereoselective expoxidation of methyl farnesonate to JHIII in the CA of 
the cockroach was found using ESTs from the CA of Diploptera punctata [6]. ESTs from D. 
punctata, Aedes aegypti and Anopheles albimanus were compared to find potential genes 
encoding enzymes involved in juvenile hormone biosynthesis. Only one enzyme, Anopheles 
orthology EAA01914, was predicted to have activity capable of converting FPP to farnesol [14]. 
However, sequences from D. melanogaster producing significant alignments with Anopheles 
EAA01914 show homology to trans-isoprenyl diphosphate synthases including farnesyl 
diphosphate synthases and geranylgeranyl diphosphate synthases, enzymes catalyzing the 
elongation of isoprenoid substrates to produce prenyl diphosphates. 
The genome of D. melanogaster harbors several genes with protein products predicted to 
be phosphatases. In our study, Phos2680 and Phos15739 were selected as the two most likely 
candidates for catalyzing FPP hydrolysis based on amino acid sequence analysis of these proteins 
with subclass I of the haloacid dehalogenase (HAD) superfamily including mammalian sEH, 
HAD, PSP, and PhAH [7, 15]. Genes CG2680 and CG15739 encode phosphatases displaying the 
three typical conserved motifs (motif I: DXDX[T/V][L/V]; motif II: [S/T]XX; and motif III: K-
[G/S][D/S]XXX[D/N]) for nucleophile attack, substrate binding, and Mg2+ binding respectively 
[16] (Fig. 1B). Both CG2680 and CG15739 were also observed in the ring gland of D. 
melanogaster using reverse transcription PCR. Six other putative phosphatases from D. 
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melanogaster were eliminated from further analysis because of a lack of structural motifs or non-
detectable expression in ring glands. 
Variant Phos15739D28A was generated by substituting residue Asp-28, the equivalent of 
hsEH Asp-9, with Ala. The purified mutant Phos15739D28A exhibited no p-NPP or FPP activities 
(data not shown), consistent with our hypothesis that Asp-28 located in motif I is the catalytic 
nucleophile of the enzyme. 
Although both Phos2680 and Phos15739 showed high catalytic activity using p-NPP, only 
Phos15739 efficiently hydrolyzed FPP and released monophosphate from the reaction. 
Previously, the enzyme thought to catalyze hydrolysis of FPP to farnesol was thought to be a 
pyrophosphatase, which releases pyrophosphate directly from FPP [2]. Our data show that 
Phos15739 is a mono-phosphatase which hydrolyzes FPP to FMP then to farnesol. 
Since FPP is a key intermediate for JH biosynthesis, a balance between synthesis and 
hydrolysis of FPP seems critical. In insects, IPP is converted to dimethylallyl diphosphate 
(DMAPP) by isopentenyl-diphosphate isomerase, followed by the condensation of IPP (5-carbon) 
into DMAPP and sequentially to GPP (10-carbon) and FPP (15-carbon) by farnesyl diphosphate 
synthetase [14]. Although IPP and GPP were substrates of Phos15739, the lower Km/Kcat of 
Phos15739 with IPP (0.027 X105 M−1 s−1) and GPP (0.39 X105 M−1 s−1) suggest these compounds 
are rather poor substrates. On the other hand, both FMP and FPP are approximately 10-fold better 
substrates for Phos15739 with Km/Kcat of 3.1X105 and 2.1 X105 M−1 s−1 (Table 1). 
Six forms of JH sharing a similar synthesis pathway have been identified and 
characterized in insects, and the relative level of JHs in insects is one of the major factors 
regulating insect development and metamorphosis [17]. The regulation of JH titer is therefore 
critical for insect maturation and thus this pathway is an attractive target for insecticide 
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development [5]. We identified Phos15739 as an insect FPPase and therefore insecticide target by 
aligning Drosophila phosphatases with the N-terminus of hsEH, however, the effect of various 
inhibitors on the hsEH phosphatase and Phos15739 were surprisingly different. In our study, N-
acetyl-S-geranylgeranyl-L-cysteine with an IC50 value of 4.4 μM was the best inhibitor of 
Phos15739. N-acetyl-S-farnesyl-L- cysteine, the best isoprenoid-derived inhibitor (IC50 as 0.84 
μM) [8], and taurolithocholic acid 3-sulfate the best sulfate inhibitor for the hsEH N-terminal 
phosphatase (IC50 equal to 5 μM) [12], however, had IC50 values of 28 and over 100 μM for 
Phos15739. Optimizing inhibitors of Phos15739 using N-acetyl-S-geranylgeranyl-L-cysteine as a 
lead compound may provide a means of disrupting JH biosynthesis and consequentially inducing 
premature metamorphosis or preventing reproduction in insects. 
The ring gland, the endocrine/neurohaemal organ of insects, includes two lateral 
prothoracic glands, corpus cardiacum and corpus allatum (CA). The CA is considered the likely 
site of synthesis and secretion of JH in D. melanogaster [18]. The expression of Phos15739 in 
ring glands was confirmed by RT-PCR using cDNA synthesis from ring glands as template. 
Therefore, to the best of our knowledge, Phos15739 is the first FPP mono-phosphatase that has 
been confirmed to be expressed in ring glands. 
In D. melanogaster, the titre of JHIII decreases from a high level in 2nd instar larvae to 
relative lower levels in 3rd instar larvae, and is undetectable in early pupa [13]. In adult females, 
JH is again synthesized as it is required to activate ovary maturation during reproduction [19, 20]. 
In males, JH has been shown to play an important role for protein synthesis in accessory glands 
[21]. Mated males have 3-fold more JH and released twice as much sex pheromone as virgin 
males, suggesting that JH is involved in the development of sexual signaling, promoting male 
mating behavior and reproductive maturity [22]. In our study, CG15739 expression was detected 
in ring glands, and high levels of transcript were detected in 2nd instar larvae and adults, whereas 
relatively lower levels of transcript were detected in 3rd instar wondering larvae and pupae of D. 
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melanogaster (Fig. 4). Our study also showed that expression levels of Phos15739 protein were 
correlated with previously reported JHIII levels. A peak of Phos15739 appeared in 2nd instar 
larvae, and decreased in the wondering stage, followed by very low expression in the pupal stage. 
Because JH titer is determined by its rate of biosynthesis, release, and degradation [3] our results 
suggest that Phos15739 might be important in regulating JH levels in vivo. 
In summary, we show that Phos15739 from D. melanogaster is localized in the ring gland 
and hydrolyzes FPP to farnesol. The coordinated expression of CG15739 with JH titer during 
development suggests a potential regulatory role in JH biosynthesis. Inhibition of this enzyme in 
vivo will be important for understanding its role in regulating JH levels and, potentially for insect 
control. 
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Figure 1: Sequence alignment of eight putative phosphatases from D. melanogaster (A) and 
sequence alignment of Phos15739, Phos2680 with N-terminal domain of hsEH (B). Boxes 
indicate the three phosphatase motifs as described by Cronin (7), and bold letters indicate the 
potential conserved residues in each motif. 
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Figure 2: RT-PCR analysis of putative phosphatase gene expression in 3rd instar Drosophila 
melanogaster larvae. (A) RT-PCR using total RNA isolated from 3rd early instar larvae as 
template, primers are listed in supplemental table 1. From left to right: CG15739 (703 bp), 
CG5567 (933 bp), CG11291 (795 bp), CG32487 (697 bp), CG32488 (612 bp), and CG2680 (962 
bp). (B) Expression of putative phosphatases in the ring glands of 3rd instar larvae by RT-PCR. 
From left to right: CG2680, CG5567, CG11291, CG15739, CG32487, and CG32488. 
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Figure 3: Thin-layer chromatography showing the production of farnesol from FPP by 
Phos15739. FPP (1 mM, 10 μL), FMP (1 mM, 10 μL), Farnesol (FOH, 1 mM, 10 uL), and 
Phos15739 (E, 400 ng in 10 μL) were used as standards. FPP and Phos15739 (E + FPP, 400ng 
and 10 μL of 1 mM respectively) were incubated at room temperature for 1 min or 30 min before 
loading. The mobile phase was hexane/ethyl acetate (4:1). 
 
 
 117 
 
Figure 4: Comparative expression of CG15739 in different developmental stages of Drosophila 
melanogaster by Q-RT-PCR. 2nd, 2nd instar larvae; 3E, 3rd instar early stage; 3W, 3rd instar 
wondering stage; pupa, pupae collected with first 4 hr; female and male adult, adult samples 
collected after eclosion. 
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Table 1. Phosphatase activity of Phos15739 with isoprenoid mono- and pyrophosphate 
substrates. 
Substrate Km (μM±S.E.) Vmax (μmol.min−1mg−1±S.E.) Kcat (s−1±S.E.) Kcat/Km (M−1 s−1) 
IMP 84 ± 27 18 ± 2.7 10 ± 1.5 1.2 × 105 
GMP 81 ± 6.7 250 ± 9.3 140 ± 5.3 18 × 105 
FMP 160 ± 20 85 ± 4.2 49 ± 2.4 3.1 × 105 
GGMPa >1000a NDa NDa NDa 
IPPb 430 ± 150 2.1 ± 0.39 1.2 ± 0.22 0.027 × 105 
GPPb 20 ± 8. 3 1.4 ± 1.5 0.78 ±0.09 250.39 × 105 
FPPb 48 ± 13 18 ± 1.8 10 ± 1.04 2. 1 × 105 
GGPPa >1000a NDa NDa NDa 
aGGMP and GGPP are poor substrates of Phos15739, kinetics could not be determined (ND) 
bValues are reported as apparent kinetics. 
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Table 2. In vitro inhibition of Phos2680 and Phos15739. 
Inhibitor 
IC50 (μM±S.E.) 
 of Phos2680 
IC50 (μM±S.E.)  
of Phos15739 
N-acetyls-geranyl-L-cysteine >100 6.3 ± 1.7 
N-acetyl-S-farnesyl-L-cysteine >100 28 ± 6.8 
N-acetyl-S-geranylgeranyl-L-cysteine 14 ± 1.9 4.4 ± 2.0 
S-Farnesyl-thioacetic acid 5.1 ± 1.4 >100 
Taurolithocholic acid 3-sulfate >100 >100 
p-NPP (640 μM and 240 μM) was used as the substrate for Phos2680 and Phos15739 
respectively. 
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Supplemental Table 1. Primers used for RT-PCR and qRT-PCR. 
 
Primer Sequences 
DM CG2680RTPCR- F2 5’- TTG TTA GGC AGC CGC TAA GT -3’ 
DM CG2680RTPCR-R2 5’- AAC CAG CAT CCA ATT CGT TC -3’ 
DM CG5567RTPCR-F2 5’- CGT CCA GTT CCT TGG TGA TT -3’ 
DM CG5567RTPCR-R2 5’- CCC AGG AAG TTG CGT TAC AT -3’ 
DM CG11291RTPCR-F2 5’- GCG ACC GGA AGT TTA AGA AG -3’ 
DM CG11291RTPCR-R2 5’- CAG CTG TTC AGC TTT TGA GC -3’ 
DM CG15739RTPCR-F2 5’- GTG GCC AAG GAA GTG AAC AT -3’ 
DM CG15739RTPCR-R2 5’- GGG GTA TCC CAA AGT TCG AT -3’ 
DM CG32487RTPCR-F2 5’- TCG ATG CAC ATG TAC GGA TT -3’ 
DM CG32487RTPCR-R2 5’- AGA CTT TCC AGA AGC GTG GA -3’ 
DM CG32488RTPCR-F2 5’- GAT CTG CTG CAC TTC CTT CG -3’ 
DM CG32488RTPCR-R2 5’- CCA ATT TCC TGG CTG TCA AA -3’ 
DM CG15739RTPCR- Forward 5’-TCT GAC CTT CCT GAC CAA CA-3’ 
DM CG15739RTPCR-Reverse 5’-AGT CCC TCG AAC TTG ATG CT-3’ 
Actin 42 Forward 5’- GGC GTG GTC GTT CCT CAT C-3’ 
Actin 42 Reverse 5’- TCT GAA GGA GCG GAA GTG TTG-3’ 
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Supplemental Table 2.  Phosphatase activity of Phos15739 and Phos2680 with p-nitrophenyl 
phosphate.  
 
Km  
(µM±S.E.) 
Vmax  
(µmol.min
-1
mg
-1
±S.E.) 
Kcat  
(s
-1
±S.E.) 
Kcat/Km  
(M
-1
 s
-1
) 
Phos15739
  240 ± 38 6.1± 0.29 3.4 ± 0.16 1.4 X 10
4 
Phos2680
  640 ± 71 36 ± 1.6 23 ± 1 3.6 X 10
4 
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